WO2010014825A1 - Slotted anchor device - Google Patents
Slotted anchor device Download PDFInfo
- Publication number
- WO2010014825A1 WO2010014825A1 PCT/US2009/052275 US2009052275W WO2010014825A1 WO 2010014825 A1 WO2010014825 A1 WO 2010014825A1 US 2009052275 W US2009052275 W US 2009052275W WO 2010014825 A1 WO2010014825 A1 WO 2010014825A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anchor
- prongs
- slotted
- suture
- slotted anchor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0487—Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/062—Needle manipulators
- A61B17/0625—Needle manipulators the needle being specially adapted to interact with the manipulator, e.g. being ridged to snap fit in a hole of the manipulator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00274—Prostate operation, e.g. prostatectomy, turp, bhp treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/0046—Surgical instruments, devices or methods, e.g. tourniquets with a releasable handle; with handle and operating part separable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00792—Plastic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00805—Treatment of female stress urinary incontinence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0404—Buttons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0417—T-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0419—H-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0448—Additional elements on or within the anchor
- A61B2017/045—Additional elements on or within the anchor snug fit within the anchor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0448—Additional elements on or within the anchor
- A61B2017/0451—Cams or wedges holding the suture by friction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0454—Means for attaching and blocking the suture in the suture anchor the anchor being crimped or clamped on the suture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0487—Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
- A61B2017/0488—Instruments for applying suture clamps, clips or locks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B2017/06052—Needle-suture combinations in which a suture is extending inside a hollow tubular needle, e.g. over the entire length of the needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
- A61B2017/06176—Sutures with protrusions, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B2017/0688—Packages or dispensers for surgical staplers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00547—Prostate
Definitions
- the disclosed embodiments relate generally to medical devices and methods, and more particularly to systems and associated methods for manipulating or retracting tissues and anatomical or other structures within the body of human or animal subjects for the purpose of treating diseases or disorders.
- Such procedures are often carried out for the purpose of treating or palliating the effects of diseases or disorders (e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, and the like) and/or for cosmetic purposes (e.g., face lifts, breast lifts, brow lifts, and the like) and/or for research and development purposes (e.g., to create animal models that mimic various pathological conditions).
- diseases or disorders e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, and the like
- cosmetic purposes e.g., face lifts, breast lifts, brow lifts, and the like
- research and development purposes e.g., to create animal models that mimic various pathological conditions.
- BPH Benign Prostatic Hyperplasia
- the prostate gland enlarges throughout a man's life.
- the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This pressure on the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate.
- the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra.
- Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer.
- This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life.
- LUTS lower urinary tract symptoms
- LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine, and the like) that cause urinary retention especially in men with prostate enlargement.
- certain medications e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine, and the like
- BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
- Medications for treating BPH symptoms include phytotherapy and prescription medications.
- plant products such as Saw Palmetto, African Pygeum, Serenoa Repens (sago palm) and South African star grass are administered to the patient.
- Prescription medications are prescribed as first line therapy in patients with symptoms that are interfering with their daily activities.
- Two main classes of prescription medications are alpha-1 a-adrenergic receptors blockers and 5-alpha-reductase inhibitors.
- Alpha-1 a-adrenergic receptors blockers block the activity of alpha-1 a-adrenergic receptors that are responsible for causing constriction of smooth muscle cells in the prostate.
- Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
- Transurethal Resection of Prostate is the most commonly practiced surgical procedure implemented for the treatment of BPH.
- prostatic urethral obstruction is reduced by removing most of the prostatic urethra and a sizeable volume of the surrounding prostate gland. This is carried out under general or spinal anesthesia.
- a urologist visualizes the urethra by inserting a resectoscope, that houses an optical lens in communication with a video camera, into the urethra such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland.
- the distal region of the resectoscope consists of an electric cutting loop that can cut prostatic tissue when an electric current is applied to the device.
- An electric return pad is placed on the patient to close the cutting circuit.
- the electric cutting loop is used to scrape away tissue from the inside of the prostate gland.
- the tissue that is scraped away is flushed out of the urinary system using an irrigation fluid.
- the loop is also used to cauterize transected vessels during the operation.
- TVP Transurethral Electrovaporization of the Prostate
- a resectoscope is inserted transurethrally such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland.
- the distal region of the resectoscope consists of a rollerball or a grooved roller electrode.
- a controlled amount of electric current is passed through the electrode.
- the surrounding tissue is rapidly heated up and vaporized to create a vaporized space.
- the region of the urethra that is blocked by the surrounding prostate gland is opened up.
- TUIP Transurethral Incision of the Prostate
- the resistance to urine flow is reduced by making one or more incisions in the prostate gland in the region where the urethra meets the urinary bladder.
- This procedure is performed under general or spinal anesthesia.
- one or more incisions are made in the muscle of the bladder neck, which is the region where the urethra meets the urinary bladder.
- the incisions are in most cases deep enough to cut the surrounding prostate gland tissue including the prostatic capsule. This releases any compression on the bladder neck and causes the bladder neck to spring apart.
- the incisions can be made using a resectoscope, laser beam, and the like.
- VLAP Visual Laser Ablation of the Prostate
- HoLEP Holmium Laser Resection/Enucleation of the Prostate
- VLAP a neodymium: Yttrium-aluminum-gamet (NdYAG) laser is used to ablate tissue by causing coagulation necrosis. The procedure is performed under visual guidance.
- a holmium: Yttrium-aluminum-gamet laser is used for direct contact ablation of tissue. Both these techniques are used to remove tissue obstructing the urethral passage to reduce the severity of BPH symptoms.
- Another example of a surgical procedure for treating BPH symptoms is Photoselective Vaporization of the Prostate (PVP).
- PVP Photoselective Vaporization of the Prostate
- laser energy is used to vaporize prostatic tissue to relieve obstruction to urine flow in the urethra.
- the type of laser used is the Potassium-Titanyl-Phosphate (KTP) laser.
- KTP Potassium-Titanyl-Phosphate
- the wavelength of this laser is highly absorbed by oxyhemoglobin. This laser vaporizes cellular water and, hence, is used to remove tissue that is obstructing the urethra.
- FIG. 1 Another example of a surgical procedure for treating BPH symptoms is Open Prostatectomy.
- the prostate gland is surgically removed by an open surgery. This is done under general anesthesia. The prostate gland is removed through an incision in the lower abdomen or the perineum. The procedure is used mostly in patients that have a large (greater than approximately 100 grams) prostate gland.
- Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
- TUMT Transurethral Microwave Thermotherapy
- TUNA Transurethral Needle Ablation
- ILC Interstitial Laser Coagulation
- Prostatic Stents include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
- TUMT Transurethral Microwave Thermotherapy
- microwave energy is used to generate heat that destroys hyperplastic prostate tissue. This procedure is performed under local anesthesia.
- a microwave antenna is inserted in the urethra.
- a rectal thermosensing unit is inserted into the rectum to measure rectal temperature. Rectal temperature measurements are used to prevent overheating of the anatomical region.
- the microwave antenna is then used to deliver microwaves to lateral lobes of the prostate gland.
- the microwaves are absorbed as they pass through prostate tissue. This generates heat which in turn destroys the prostate tissue.
- the destruction of prostate tissue reduces the degree of squeezing of the urethra by the prostate gland, thus, reducing the severity of BPH symptoms.
- TUNA Transurethral Needle Ablation
- heat-induced coagulation necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using local anesthetic and intravenous or oral sedation.
- a delivery catheter is inserted into the urethra.
- the delivery catheter comprises two radiofrequency needles that emerge at an angle of 90 degrees from the delivery catheter.
- the two radiofrequency needles are aligned at an angle of 40 degrees to each other so that they penetrate the lateral lobes of the prostate.
- a radiofrequency current is delivered through the radiofrequency needles to heat the tissue of the lateral lobes to 70-100 degree Celsius at a radiofrequency power of approximately 456 KHz for approximately 4 minutes per lesion. This creates coagulation defects in the lateral lobes. The coagulation defects cause shrinkage of prostatic tissue which in turn reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
- ILC Interstitial Laser Coagulation
- a cystoscope sheath is inserted into the urethra, and the region of the urethra surrounded by the prostate gland is inspected.
- a laser fiber is inserted into the urethra. The laser fiber has a sharp distal tip to facilitate the penetration of the laser scope into prostatic tissue.
- the distal tip of the laser fiber has a distal-diffusing region that distributes laser energy 360° along the terminal 3 mm of the laser fiber.
- the distal tip is inserted into the middle lobe of the prostate gland, and laser energy is delivered through the distal tip for a desired time. This heats the middle lobe and causes laser- induced necrosis of the tissue around the distal tip. Thereafter, the distal tip is withdrawn from the middle lobe.
- the same procedure of inserting the distal tip into a lobe and delivering laser energy is repeated with the lateral lobes. This causes tissue necrosis in several regions of the prostate gland which, in turn, causes the prostate gland to shrink. Shrinkage of the prostate gland reduces the degree of squeezing of the urethra by the prostate, thus, reducing the severity of BPH symptoms.
- Prostatic Stents are flexible devices that are expanded after their insertion in the urethra. They mechanically support the urethra by pushing the obstructing prostatic tissue away from the urethra. This reduces the constriction of the urethra and improves urine flow past the prostate gland thereby reducing the severity of BPH symptoms.
- Surgical treatments of BPH carry a risk of complications including erectile dysfunction; retrograde ejaculation; urinary incontinence; complications related to anesthesia; damage to the penis or urethra; need for a repeat surgery; and the like.
- TURP which is the gold standard in treatment of BPH, carries a high risk of complications. Adverse events associated with this procedure are reported to include retrograde ejaculation (65% of patients), post-operative irritation (15%), erectile dysfunction (10%), need for transfusion (8%), bladder neck constriction (7%), infection (6%), significant hematuria (6%), acute urinary retention (5%), need for secondary procedure (5%), and incontinence (3%).
- Typical recovery from TURP involves several days of inpatient hospital treatment with an indwelling urethral catheter, followed by several weeks in which obstructive symptoms are relieved, but there is pain or discomfort during micturition.
- the reduction in the symptom score after minimally invasive procedures is not as large as the reduction in symptom score after TURP. Up to 25% of patients who receive these minimally invasive procedures ultimately undergo a TURP within 2 years.
- the improvement in the symptom score generally does not occur immediately after the procedure. For example, it takes an average of one month for a patient to notice improvement in symptoms after TUMT and 1.5 months to notice improvement after ILC. In fact, symptoms are typically worse for these therapies that heat or cook tissue, because of the swelling and necrosis that occurs in the initial weeks following the procedures. Prostatic stents often offer more immediate relief from obstruction but are now rarely used because of high adverse effect rates.
- Stents have the risk of migration from the original implant site (up to 12.5% of patients), encrustation (up to 27.5%), incontinence (up to 3%), and recurrent pain and discomfort. In published studies, these adverse effects necessitated 8% to 47% of stents to be explanted. Overgrowth of tissue through the stent and complex stent geometries has made their removal quite difficult and invasive.
- catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation.
- drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
- these procedures are performed by creating incisions through the skin, dissecting to a plane beneath muscles and fascia, freeing the muscles, fascia and overlying skin from underlying structures (e.g., bone or other muscles), lifting or repositioning the freed muscles, fascia and overlying skin, and then attaching the repositioned tissues to underlying or nearby structures (e.g., bone, periostium, or other muscles) to hold the repositioned tissues in their new (e.g., lifted) position. In some cases, excess skin may also be removed during the procedure.
- underlying structures e.g., bone or other muscles
- connector suspension lifts have been developed where one end of a standard or modified connector thread is attached to muscle and the other end is anchored to bone, periostium or another structure to lift and reposition the tissues as desired.
- Some of these connector suspension techniques have been performed through cannulas or needles inserted though relatively small incisions of puncture wounds.
- the present disclosure is directed towards a slotted suture anchor which includes a back end that resembles a flattened tube in shape, with a width in lateral cross-section that is greater than its thickness.
- the slotted suture anchor also includes a pair of spaced apart prongs.
- the spaced prongs join together at a slot inception.
- the prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs.
- the mechanism of suture attachment and strength of the assembly is a combination of compression of the suture between the stiff slotted prongs of the anchor as well as disruption of the suture surface by the discreet edges of the slotted, flattened-tubular anchor.
- the discreet edges provide a lower contact surface area between anchor prongs and suture and focuses the compressive forces in focal points that cause the suture to conform around both internal recesses and external faces.
- the prongs include inwardly facing protrusions that are configured to capture and deform the suture between the protrusions and prevent the suture from disengaging from the slotted anchor device once engaged.
- slotted anchors are also contemplated.
- a pair of rigid prongs are provided so that a grip onto a connector can be achieved without the necessity or significant reliance upon an additional locking member.
- various embodiments of slotted structures are disclosed which accordingly provide alternative approaches to inward extending protrusions as well as the slot inception of the device.
- FIG. 1 is a perspective view of one embodiment of an anchor assembly that includes a distal anchor and a proximal anchor secured together by a suture;
- FIG. 2 is a top view of one embodiment of a slotted anchor
- FIG. 3 A is a cross section of the suture and the slotted anchor assembly taken along lines 3 A-3 A of FIG. 1;
- FIG. 3B is a cross section of the anchor assembly taken along lines 3B-3B of FIG. 1;
- FIG. 4 is a close up perspective view of the slot inception, wider seating region, and inwardly facing protrusions of the slotted anchor of FIG. 2;
- FIG. 5 is a perspective view of another embodiment of a slotted anchor
- FIG. 6 is top view of the slotted anchor of FIG. 5;
- FIG. 7 is a close up perspective view of the slot inception, wider seating region, and inwardly facing protrusions of the slotted anchor of FIG. 5;
- FIG. 8 is a perspective view of the distal anchor with a orthogonally oriented tail portion
- FIG. 9 is a side view of the distal anchor with a orthogonally oriented tail portion of FIG. 8 and the suture in an in-line configuration;
- FIG. 10 is a cross sectional view of an anchor assembly of FIG. 1 implanted through the prostate of an individual with benign prostatic hyperplasia;
- FIG. 11 is a perspective view of a slotted anchor
- FIG. 12 is a top view of the slotted anchor of FIG. 11;
- FIG. 13 is a perspective view of a slotted anchor having tapered prongs that converge towards a circular seating region before the slot inception;
- FIG. 14 is a top view of the slotted anchor of FIG. 13;
- FIG. 15 is a perspective view of a slotted anchor having tapered prongs that converge towards a serrated seating region before the slot inception;
- FIG. 16 is a close up top view of the slotted anchor of FIG. 15;
- FIG. 17 is a perspective view of a slotted anchor having tapered prongs that converge towards a barbed seating region before the slot inception;
- FIG. 18 is a close up top view of the slotted anchor of FIG. 17;
- FIG. 19 is a perspective view of a slotted anchor having a tubular shape and tapered prongs that converge towards inwardly facing protrusions in the seating region before the slot inception;
- FIG. 20 is a side view of the slotted anchor of FIG. 19;
- FIG. 21 is an end view of the slotted anchor of FIG. 19;
- FIG. 22 is a top view of a slotted anchor having prongs that begin a tapered convergence before turning parallel towards a triple-barbed slot inception;
- FIG. 23 is a close up perspective view of the top layer of the slotted anchor of FIG.
- FIG. 24 is a top view of a slotted anchor having prongs that begin a tapered convergence before turning parallel towards a circular slot inception;
- FIG. 25 is a close up perspective view of the top layer of the slotted anchor of FIG.
- FIG. 26 is a perspective view of an unfolded slotted anchor, wherein one side of the anchor has an inwardly protruding seating region that is an inverted configuration from the other side of the inwardly protruding seating region of the anchor;
- FIG. 27 is a perspective view of the folded slotted anchor of FIG. 26;
- FIG. 28 is a top view of the folded slotted anchor of FIG. 26;
- FIG. 29 is a perspective view of an unfolded slotted anchor having oppositely tapered prongs that converge towards the oblong slot inception;
- FIG. 30 is a top view of the folded slotted anchor of FIG. 29;
- FIG. 33 is a cross-sectional view of the slotted anchor of FIG. 31 taken along line 33- 33 of FIG. 32;
- FIG. 34 is a perspective view of a slotted anchor having a slit in its side along its length
- FIG. 35 is a top view of the slotted anchor of FIG. 34;
- FIG. 36 is a cross-sectional view of the slotted anchor of FIG. 34 taken along line 36- 36 of FIG. 35;
- FIG. 37 is a perspective view of a slotted anchor wherein the top half of the anchor has an inverted configuration from the bottom of the anchor to create three slots of intersection with the suture;
- FIG. 38 is an end view of the slotted anchor of FIG. 37;
- FIG. 39 is a perspective view of a slotted anchor that is substantially square in cross- section, but is otherwise similar to the slotted anchor of FIG. 4;
- FIG. 40 is a top view of a slotted anchor that incorporates a slit along its top, and is formed into a substantially square shaped member in cross-section that is folded over on itself towards its center
- FIG. 41 is a cross-sectional view of the slotted anchor of FIG. 40;
- FIG. 42 is a perspective view of the slotted anchor of FIG. 40;
- FIG. 43 is a perspective view of a slotted anchor that incorporates a slit along its top and has one prong with a shorter height than the other prong;
- FIG. 44 is a cross-sectional view of the slotted anchor of FIG. 43;
- FIG. 45 is a cross-sectional, perspective view of the slotted anchor of FIG. 43. DETAILED DESCRIPTION
- the disclosed embodiments are illustrated with regard to anchor assemblies configured to be delivered within a patient's body.
- the disclosed embodiments can be employed for various medical purposes including but not limited to approximating, retracting, lifting, compressing, supporting or repositioning tissues, organs, anatomical structures, grafts or other material found within a patient's body. Such tissue manipulation is intended to facilitate the treatment of diseases or disorders.
- the disclosed embodiments have applications in cosmetic or reconstruction purposes, or in areas relating to the development or research of medical treatments. Referring now to the drawings, wherein like reference numerals denote like or corresponding components throughout the drawings and, more particularly to FIGS. 1-7, there is shown an embodiment of an anchor assembly .
- one portion of an anchor assembly is positioned and implanted against a first section of anatomy.
- a second portion of the anchor assembly is then positioned and implanted adjacent to a second section of anatomy for the purpose of approximating, retracting, lifting, compressing, supporting or repositioning one section of anatomy with respect to the other section of anatomy, as well as for the purpose of approximating, retracting, lifting, compressing, supporting or repositioning one section of anatomy with respect to the other section of anatomy.
- both a first and second portion of the anchor assembly can be configured to accomplish the desired approximating, retracting, lifting, compressing, supporting or repositioning of anatomy due to tension supplied thereto via a connector assembly (e.g., suture) affixed to the first and second portions of the anchor assembly.
- a connector assembly e.g., suture
- the anchor assembly is configured to include structure that is capable of being implanted within a patient's body.
- the anchor assembly may also be used in conjunction with a conventional remote viewing device (e.g., an endoscope) so that an interventional site can be observed.
- a conventional remote viewing device e.g., an endoscope
- the anchor assembly can be placed at an intervention site using a delivery tool (See co-pending U.S. Application No. 11/318,240).
- a delivery tool See co-pending U.S. Application No. 11/318,240.
- One specific, non-limiting application of the delivery tool is for the treatment of benign prostatic hyperplasia.
- an implant is delivered to a prostatic lobe that is obstructing the urethral opening and restricting flow.
- the implant compresses the lobe, thereby increasing the urethral opening and reducing the fluid obstruction through the prostatic urethra.
- the anchor assembly is embodied in a tissue approximation anchor (TAA).
- TAA tissue approximation anchor
- the tissue approximation anchor is an implant assembly that includes one tubular member, referred to as the capsular anchor or, more generally, distal anchor 70.
- the distal anchor 70 is preferably connected by a suture (preferably polyester) 78 to a slotted, flattened-tubular member (preferably comprised of stainless steel), referred to as the urethral anchor or proximal anchor 84.
- the distal anchor 70 is comprised of an electro-polished Nitinol (nickel titanium alloy SE508, 50.8% nickel) tube.
- the tissue approximation anchor is designed to be useable in an office environment (in contrast to requiring a hospital environment) with a delivery tool.
- the delivery tool is used through a 19 Fr sheath in one preferred embodiment, while in another embodiment a sheath size of 2 IF is employed. Additionally, the material selection and construction of the tissue approximation anchor still allows for a subsequent TURP procedure to be performed, if necessary, on the prostate.
- a needle delivery mechanism (as described in U.S. Application No. 11/318,246) is used to implant a nitinol distal anchor 70 and attached suture 78.
- the slotted anchor 84 is pushed by the delivery tool and captures the suture 78 transverse to the anchor axis.
- the flattened portion of the anchor 84 allows the anchor to be held by the tool without rotating so that it will stay oriented properly to ensure the suture enters the space between the prongs.
- the seating region in the slotted anchor for the suture is shown in approximately the midpoint of the slotted anchor but it is within the scope of the present invention to locate the seating region closer to one end or the other of the anchor in order to prevent the ends of the prongs of the anchor from digging into tissue after implantation but rather sit more parallel to the tissue, if so desired.
- the nitinol tube is attached to a USP size 0 PET (Poly Ethylene Terephthalate) monofilament suture 78 by thermally forming the suture to locking features on the anchor 70.
- the PET suture is a round monofilament extrusion / pulltrusion composed of a grade 8816 polyethylene terephthalate.
- the base material for the suture is annealed at approximately 100 degrees Celsius for approximately 130 minutes in a straight condition.
- the PET suture 78 has a diameter of 0.015 inches and a tensile strength greater than or equal to 12.7 pounds.
- the anchor 84 is a 316L stainless steel flattened tube that is slotted, electro-polished, and passivated.
- the anchor is depicted in the figures with a flat surface on the top or bottom but it is within the scope of the present invention that only one of the surfaces be flat and that the surface(s) do not have to be true flat but rather could have a slight dip or protrusion on the flattened surfaces.
- the slotted anchor 84 includes prongs 96 that grip and deform the suture 78 in the seating region 98 between the spaced prongs 96.
- the seating region can be formed by staggered structure or one prong can have a longer area defining seating structure than an opposing prong to provide an effective engagement for a particular suture or connector design.
- the prongs 96 are quite stiff and robust therefore subject to minimal to no deflection.
- the prongs or overall width of the anchor adjacent the seating region 98 expands, after a connector has been seated in the seating region, less than about 0.002 inches (i.e., less than about five percent), more preferably less than about .001 inches (i.e., less than about two and half percent).
- the prongs or overall width of the anchor adjacent the ends of the prongs 96 expands, after a connector has been seated in the seating region, less than about 0.0065 inches (i.e., less than about seventeen percent), more preferably less than about .006 inches (i.e., less than about fifteen percent). Due to its particular configuration, the slotted anchor 84 also requires less force to deploy onto a suture 78. Being relatively stiff, the prongs 96 of the slotted anchor 84 are significantly more resistant to bending.
- the four individual edges/faces (two on each prong 96) of the slotted anchor 84 disrupt the surface of the suture 78, both biting into the suture 78 as well as compressing the suture 78 between the slotted prongs 96, including sometimes melting the suture locally due to the pressure and heat created during deployment of the slotted anchor onto the suture.
- the reduced area of contact provided by this structure as well as multiple planes of engagement of the anchor slot to the connector strengthens connections and prevents inadvertent separation.
- the narrow width of the slot inception 97 is substantially smaller than the connector diameter, with the purpose to allow the stiffer prongs to slightly elastically expand over the connector and contribute to anchor retention by means of compression but not intended to receive the connector into this relief slot, which is positioned proximal to the seating portion 98. It is beneficial in some circumstances however for the slotted anchor to be pushed far enough on to the connector such that the connector becomes at least partially seated in the slot inception relief slot so that it becomes pinched and/or wedged.
- the outwardly stepped slot width also has a dimension smaller than the connector diameter, and receives the connector with some interference.
- the prongs 96 are formed from a wide (or flattened) tubular structure.
- the wider and smoother prongs 96 of the anchor 84 assist in preventing the prongs 96 from irritating and/or damaging tissue, which is more likely to occur with a thinner and pointier leg structure forming piercing structure.
- the slot in the anchor 84 is configured to create registering and aligning surfaces to the delivery tool (not shown).
- the two inner surfaces of the prongs 96 of the slotted anchor 84 are configured as corresponding inwardly facing U-shapes. In this configuration, the inner surfaces of the prongs 96 bite into the suture 78.
- the two inner surfaces of the prongs 96 of the slotted anchor 84 are configured to present a notched geometry.
- the inner surfaces of the prongs are configured with burrs, roughened edges, serrations, etc. to enhance their ability to retain the connector.
- the slotted anchor 84 includes a rigid generally tubular or flattened cylindrical back end 95, extending from which are a pair of spaced prongs 96.
- the anchor assembly may be filled in with a radiopaque material, or other therapeutic agent.
- Terminal ends of the prongs 96 may be tapered to receive a section of the suture 78.
- the prong structure commences at a narrowed slot inception 97, which steps outwardly to a wider dimension to thereby define the space between the prongs 96.
- This narrow slot 97 provides the slotted anchor 84 with desired structural rigidity to receive the suture 78 and to facilitate locking engagement with the slotted anchor 84.
- the space between the prongs 96 of the slotted anchor 84 is dimensioned relative to the diameter of the suture 78 such that is has sufficient gripping force moving toward the seating region 98 to obviate the need for a securing end unit. Accordingly, in a preferred embodiment, a securing end unit is not needed.
- the slot inception 97 is not intended to receive a connector or suture 78 but rather it provides the prongs with the slight flexibility to receive the suture 78 in a manner so that the suture 78 is positioned as desired within the seating region. Such desired positioning creates a lock between the anchor 84 and the suture 78 thereby providing the clinical benefit of preventing loss of tension between members forming an anchor assembly.
- shaped tube raw stock is used to produce the anchor 70 and the anchor 84 using slot/profile cutting.
- the raw stock may be cut by laser, wire-EDM, or stamped from a flat and formed into a shape.
- the raw stock has a total height ranging from 0.020 inches to 0.025 inches, and has a total width ranging from 0.038 inches to 0.040 inches. Thus, this raw stock is flatter and wider than a purely round tube would be.
- the inwardly facing protrusion region 99 on the prongs 96 is configured to keep the suture 78 from "walking" out over time.
- the inner surface of the prongs 96 near the slot inception 97 is more of an extended landing (i.e., wider seating region 98) than a simple U-shaped surface configuration.
- Various of the contemplated embodiments can include such landings and the landings can assume curved or other shapes.
- the inner surface of the prongs 96 can have alternative configurations differing from a U-shape. Non-flat inner surfaces tend to facilitate retention of a suture 78 under tension such as exemplified in FIG.
- FIG. 3B which depicts a suture forming a hourglass shape between opposing surfaces of prongs 96.
- the outer surfaces of the prongs 96 are contemplated to define an atraumatic structure such as that provided by curved surfaces.
- the prongs 96 have a straight lead-in initially before beginning to taper.
- the prongs have a tapered lead-in configuration with additional inward protrusions 100. This tapered lead-in configuration with additional inward protrusions 100 assists with the centering of the suture 78 into the seating region 98 and facilitated placement of the anchor onto the suture 78.
- a 0.014 inch gap between prongs 96 provides a structure suitable for use with a 0.015 inch suture 78 while allowing minimal to no tissue impingement.
- the seating region 98 of the slot has a 0.008 inch gap while the inwardly protruding region 99, which helps prevent a suture 78 from walking out over time, has a 0.006 inch gap.
- the seating region 98 of the slot has a 0.009 inch gap, while the inwardly protruding region 99, has a 0.007 inch gap.
- seating region 98 is approximately 0.011 inches.
- slot parameters include, by way of example only, and not by way of limitation: width, thickness, length, and profile.
- FIGS. 8-10 One embodiment of an anchor assembly 10 is depicted in FIGS. 8-10.
- the anchor 70 In its unconstrained configuration, the anchor 70 includes a tubular (head) portion 72 which is generally orthogonally oriented to a tail portion 74. It is to be noted, however, that while housed in a delivery assembly and prior to deployment at a target area, the anchor 70 is constrained to define a generally straight configuration, only subsequently assuming the unconstrained (i.e., orthogonally oriented) configuration upon deployment from a delivery device.
- the anchor 70 is laser cut or wire EDM (electrical discharge machined) from a Nitinol base stock that is generally-tubular in shape.
- the nitinol anchor is shape-set to have a "flipping tail" and is electro-polished.
- the suture 78 is then attached to the anchor 70.
- the PET suture 78 is thermoformed onto locking features in the anchor 70.
- the anchor 70 may be locally heated to re-flow the suture onto the end of the anchor 70 and into cutouts on the anchor 70.
- the post electro-polished anchor 70 has a 0.016 inner diameter and a 0.0245 outer diameter.
- the tubular portion 72 of the anchor 70 includes a plurality of tabs 76 which can be deformed or deflected to accomplish affixing the anchor 70 to a suture 78. It has been found that three such tabs 76, two on one side of the tubular portion 72 and one on an opposite side, provide a sufficient connecting force.
- the anchor 70 may be attached to the suture 78 through any of several known techniques, such as by being attached to the distal end of the tubular portion 72.
- the anchor 70 can be laser cut from a tube formed of Nitinol or other appropriate material.
- a mid-section 80 of the distal anchor 70 provides a structural transition from the tubular portion 72 to the tail portion 74.
- a portion of a side wall is removed in the mid-section area 80.
- a further portion of the side wall is removed to define a connector section 82 of the tail 74 which extends from the mid-section 80.
- this connector section 82 includes a bend that creates the orthogonally or obliquely oriented configuration.
- This connector section 82 acts as a barb or deflected strut to cause rotation of the anchor 70 relative to the suture 78 after deployment from a delivery tool (creating a "flipping tail") and produce the relative unconstrained (orthogonally oriented) angle assumed between the tail 74 and tubular portion 72 of the anchor 70.
- the recovered shape of the terminal end portion 83 of the anchor presents a transverse strut that engages tissue when the suture is tensioned.
- the anchor assembly in its implanted form (FIG. 1), can include an anchor 70 (e.g., first anchor) whose initial engagement with a suture 78 is generally coaxial, and an anchor 84 (e.g., second anchor) with an initial engagement being generally perpendicular with the suture 78.
- the anchor 70 is "unsheathed" from a needle delivery device (not shown) once positioned for reliable deployment
- An anchor assembly ejected from a terminal end of a delivery device and implanted across a prostate is shown in FIG. 10.
- each of these disclosed embodiments may include structure accomplishing an engagement with a connector without requiring a secondary locking component. Such a secure engagement can be provided by an interference between anchor structure and the connector resulting in deformation of the connector.
- FIGS. 11-12 an embodiment of a slotted anchor 1184 having a flattened tubular shape is shown.
- the slotted anchor 1184 has a width in lateral cross-section that is greater than its thickness, as well as tapered prongs 1196 that meet at a circular slot inception 1197 after passing inwardly facing protrusions 1199 and a seating region 1198 for the suture 78.
- This embodiment lacks a "relief slot" at the slot inception 1197 (as shown in FIGS. 5-7), but instead has only the above-described circular seating region 1198 for receiving the suture 78.
- FIGS. 13-14 illustrate an embodiment of a slotted anchor 1384 having a flattened tubular shape.
- the slotted proximal anchor 1384 has a width in lateral cross- section that is greater than its thickness.
- the anchor further includes tapered prongs 1396 that converge towards a circular seating region 1398 after passing inwardly facing protrusions 1399 and before reaching a generally U-shaped, more narrowly dimensioned slot inception 1397.
- This embodiment includes a "relief slot" at the slot inception 1397 for receiving the suture 78. Additionally, the relief slot may reduce stress concentration in the anchor when the suture is seated.
- the slotted anchor 1584 also having a flattened tubular shape is shown.
- the slotted anchor 1584 includes tapered prongs 1596 that converge towards a seating region 1598 after passing a plurality of inwardly facing serrated protrusions 1599 and before the slot inception 1597.
- the surfaces forming apices of the serrated region have generally equal dimensions.
- the serrated region 1599 can also define or embody a portion of a seating region.
- the serrated region 1599 can function to lock into and grasp a connector to thereby result in a firm engagement as well as provide a lower surface area for contacting a suture being placed therethrough.
- the apices of the serrated region cause more deformation than many of the previously discussed surfaces without abrading the suture 78.
- FIGS. 17-18 Another embodiment of a slotted anchor 1784 having a flattened tubular shape and a serrated region is shown in FIGS. 17-18.
- tapered prongs 1796 converge towards a seating region 1798 extending from a slot inception 1797 after passing a serrated region formed by inwardly facing barbed protrusions 1799.
- the barbed protrusions 1799 of the serrated region are formed by surfaces of different dimensions, thus forming more of a barbed shape.
- Such a barbed shape is intended to facilitate sufficient gripping forces on a suture 78.
- a slotted proximal anchor 1784 with a barbed serrated region preferably is used in conjunction with a tougher type of suture 78 that is resistant to abrasion.
- the slotted proximal anchor 1984 has tapered prongs 1996 that converge toward inwardly facing protrusions 1999 adjacent the seating region 1998 before reaching the slot inception 1997.
- the angle formed by the tapered prongs, the protrusion and relatively narrow dimension of the seating region cooperate to create a substantial engagement with a connector.
- the protrusions 1999 cause moderate deformation of the suture 78 while minimizing abrasion of the suture.
- FIGS. 22-23 show an embodiment of a slotted anchor 2284 having a generally rectangular shape and that has been formed by stamping a flat sheet of metal that is folded over at the leading end of the prongs 2296 to form two layers (only one layer is shown).
- the slotted anchor 2284 has a width in lateral cross-section that is greater than its thickness.
- the anchor also includes prongs 2296 that define a tapered convergence before turning parallel towards inwardly facing barbed protrusions 2299, one projecting from each prong.
- the anchor also includes a seating region 2298 configured adjacent a barbed slot inception 2297.
- the barbed slot inception 2297 and barbed protrusions 2299 cooperate to deform and grasp a suture 78.
- these barbed protrusions create more point pressure or "bite" into the suture 78and therefore is contemplated to be used in conjunction with a tougher type of suture 78 that is more resistant to abrasion.
- FIGS. 24-25 there is shown another embodiment of a slotted anchor 2484 having a generally rectangular portion that has been formed by folding over a flat sheet (only one layer is shown).
- the slotted proximal anchor 2484 has a width in lateral cross-section that is greater than its thickness transverse to the axis of the suture 78, and prongs 2496 that begin a tapered convergence before turning parallel towards a seating region 2498 formed at a circular slot inception 2497.
- This circular slot inception 2497 creates a compression ring to secure the suture 78.
- This type of compression ring tends to deform the suture 78 without abrading the suture 78 (i.e., less "bite” into the suture).
- This embodiment also has expanded width prongs 2496.
- the terminal ends of the prongs 2496 diverge in a manner such that they span a dimension greater than the width of the rectangular portion.
- Such structure facilitates receiving the connector and guides it to the seating region 2498 as the anchor 2484 is moved into engagement with the suture.
- another embodiment of a slotted anchor 2684 has tapered prongs 2696 that converge toward inward protrusions 2699 and a seating region 2698 before reaching the circular slot inception 2697.
- This anchor 2684 can be formed by stamping or cutting of flat metal stock to produce an elongated member and then folding the member in half.
- the pattern formed into the structure defines the inward protrusions 2699, seating region 2698, and circular slot inception 2697.
- one side of the anchor 2684 has inward protrusions 2699 that are an inverted configuration from the inward protrusions 2699 on the other side of the anchor 2684 to form structure well suited to grip a connector.
- This embodiment has an oblong seating region 2698 for receiving the suture 78.
- a unitary body may be produced by tack welding or laser welding the anchor 2684 together. This type of slotted anchor 2684 is generally easier to manufacture.
- FIGS. 29-30 another embodiment of a slotted anchor 2984 formed from a folded member is shown.
- the slotted proximal anchor 2984 when folded, has a width in lateral cross-section that is greater than its thickness and oppositely tapered prongs 2996 that converge toward inward protrusions 2999 and a seating region 2998 before reaching the slot inception 2997.
- one side of the anchor 2984 has oppositely tapered prongs 2996 that are an inverted configuration from the other side of the oppositely tapered prongs 2996 of the anchor 2984.
- This embodiment has an oblong seating region 2998 for receiving the suture 78.
- FIGS. 31-33 depict an embodiment of a slotted anchor 3184 having a slit that extends along its top.
- This anchor is produced using an alternative forming technique, namely the flat sheet is rolled along its length rather than being folded at its ends as described before.
- the anchor defines a C-shape (See FIG. 33).
- the slotted anchor 3184 again has a width in lateral cross-section that is greater than its thickness and includes tapered prongs 3196.
- the prongs 3196 converge toward inward protrusions 3199 and continue to a circular seating region 3198 before reaching the slot inception 3197.
- the prongs 3196 include inwardly facing protrusions at their terminal ends that increase the stiffness of the prongs 3196, as well as reducing possible irritation of the surrounding tissue when implanted. If desired, during manufacturing, the anchor 3184 can be clamped down to close the slit that extends along its length. As described above, a unitary body may be produced by tack welding or laser welding the anchor 2984 together in some embodiments.
- FIGS. 34-36 an embodiment of a slotted anchor 3484 having a slit extending along the outside wall of one of the prongs 3496.
- a cross-section of the anchor 3484 defines a U shape (See FIG. 36).
- the slotted anchor 3484 has a width in lateral cross-section that is greater than its thickness and tapered prongs 3496 that converge toward inward protrusions 3499 and a circular seating region 3498.
- the circular seating region 3498 is configured adjacent a slot inception 3497.
- the prongs 3496 include inwardly facing protrusions at their terminal ends.
- a slotted anchor 3784 that is formed from an S-shaped folded member is depicted in FIGS. 37-38.
- the slotted anchor 3784 includes structure forming tapered prongs 3796 that converge towards a semi-circular seating region 3798 formed adjacent the slot inception 3797.
- the top half of anchor 3784 has an inverted configuration from the bottom of the anchor 3784 to create multiple places capable of intersecting with a suture.
- the prongs 3196 generate three layers for gripping the suture. It is within the scope of the present invention to provide multiple layers of engagement with the suture.
- FIG. 39 an embodiment of a slotted anchor 3984 is shown.
- the slotted anchor 3984 is quite similar to the slotted anchor 84 shown in FIG. 4, except that the slotted anchor 3984 of FIG. 39 is substantially square in cross-section. Additionally, the prongs 3996 of the slotted anchor 3984 are significantly shorter than the prongs 96 of the slotted anchor 84 shown in FIG. 4.
- This embodiment includes a "relief slot” at the slot inception 3997and a seating region 3998.
- a slotted anchor 4084 incorporates a slit in its top, and is formed into a substantially square shaped member that is folded over on itself towards its center. This "folded over" region produces a greater surface area that is in contact with the suture 78, and thus, creates a larger amount of deformation of the suture 78 and friction against the suture 78.
- the slotted anchor 4084 includes a structure forming tapered prongs 4096 that converge towards protrusions 4099 and a seating region 4098 formed adjacent to the slot inception 4097.
- a slotted anchor 4384 incorporates a slit in its top, and has one prong 4396 with a shorter height than the other prong.
- the slotted anchor 4384 includes structure forming tapered prongs 4396 that converge towards inward protrusions 4399 and seating region 4398 formed adjacent the slot inception 4397.
- This anchor's configuration which incorporates one prong 4396 with a shorter height than the other prong, creates multiple places at different heights capable of intersecting with a suture 78.
- the prongs 4396 generate less distortion of the suture 78, but more friction against the suture.
- the disclosed embodiments contemplate both pushing directly on anchor portions of an anchor assembly as well as pushing directly upon the connector of the anchor assembly. Further, an anchor assembly can be delivered and deployed at an interventional site by a deployment device. Consequently, in the context of prostate treatment, the disclosed embodiments accomplish both compressing of the prostate gland and the opening of the prostatic urethra and applying tension between ends of the implant. Moreover, drug delivery is contemplated as a further remedy in BPH and over-active bladder treatment.
- the anchor assembly of the disclosed embodiments accomplishes desired tissue approximation, manipulation, compression or retraction, as well as cooperates with the target anatomy to provide an atraumatic support structure.
- the shape and contour of the anchor assembly can be configured so that the assembly invaginates within target tissue, such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly.
- target tissue such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly.
- wispy or pillowy tissue in the area collapses around the anchor structure.
- the natural tissue can grow over the anchor assembly, and new cell growth occurs over time.
- Such cooperation with target tissue facilitates healing and avoids unwanted side effects such as calcification or infection at the interventional site.
- Manners in which healing can be promoted can include employing abrasive materials, textured connectors, biologies and drugs.
- connection of an anchor assembly can be severed and a proximal (or second) anchor component removed from the patient's body.
- a proximal anchor component removed from the patient's body.
- the physician can simply cut the connector and simultaneously remove the second anchor previously implanted for example, in the patient's urethra.
- various materials are contemplated for manufacturing the disclosed devices.
- one or more components such as distal anchor 70, proximal anchor 84, suture 78, of the one or more anchor assemblies disclosed herein may be designed to be completely or partially biodegradable or bio-fragmentable.
- the systems and methods disclosed herein may be used to treat a variety of pathologies in a variety of tubular structures comprising a cavity or a wall.
- organs include, but are not limited to urethra, bowel, stomach, esophagus, trachea, bronchii, bronchial passageways, veins (e.g. for treating varicose veins or valvular insufficiency), arteries, lymphatic vessels, ureters, bladder, cardiac atria or ventricles, uterus, fallopian tubes, and the like.
Abstract
A slotted anchor that secures to a connector as part of an anchor assembly is disclosed. The slotted anchor includes a pair of spaced apart prongs which join together at a slot inception. The prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs. The prongs include inwardly facing protrusions that are configured to capture and deform the connector between the protrusions and prevent the connector from disengaging from the slotted anchor once engaged.
Description
SLOTTED ANCHOR DEVICE
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation-in-part of copending United States Patent Application No. 11/775,162 entitled Multi- Actuating Trigger Anchor Delivery System, filed July 9, 2007, which is a continuation-in-part of copending United States Patent Application No. 11/671,914, entitled Integrated Handle Assembly For Anchor Delivery System, filed February 6, 2007, which is a continuation-in-part of copending United States Patent Application No. 11/492,690, entitled Apparatus and Method for Manipulating or Retracting Tissue and Anatomical Structure, filed on July 24, 2006, which is a continuation-in-part of copending United States Patent Application Serial No. 11/318,246, entitled Devices, Systems and Methods or Retracting, Lifting, Compressing, Supporting or Repositioning Tissues or Anatomical Structures, filed on December 22, 2005, which is a continuation-in-part of copending United States Patent Application Serial No. 11/134,870 entitled Devices, Systems and Methods for Treating Benign Prostatic Hyperplasia and Other Conditions, filed on May 20, 2005, the entire disclosures of which are expressly incorporated herein by reference and claims the benefit of Provisional Application Serial No. 61/084,937.
FIELD OF THE INVENTION
[0002] The disclosed embodiments relate generally to medical devices and methods, and more particularly to systems and associated methods for manipulating or retracting tissues and anatomical or other structures within the body of human or animal subjects for the purpose of treating diseases or disorders.
BACKGROUND
[0003] There are a wide variety of situations in which it is desirable to lift, compress or otherwise reposition normal or aberrant tissues or anatomical structures (e.g., glands, organs, ligaments, tendons, muscles, tumors, cysts, fat pads, and the like) within the body of a human or animal subject. Such procedures are often carried out for the purpose of treating or palliating the effects of diseases or disorders (e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, and the like) and/or for cosmetic purposes (e.g., face lifts, breast lifts, brow lifts,
and the like) and/or for research and development purposes (e.g., to create animal models that mimic various pathological conditions). In many of these procedures, surgical incisions are made in the body, and laborious surgical dissection is performed to access and expose the affected tissues or anatomical structures. Thereafter, in some cases, the affected tissues or anatomical structures are removed or excised. In other cases, various natural or man-made materials are used to lift, sling, reposition or compress the affected tissues.
[0004] Benign Prostatic Hyperplasia (BPH):
[0005] One example of a condition where it is desirable to lift, compress or otherwise remove a pathologically enlarged tissue is Benign Prostatic Hyperplasia (BPH). BPH is one of the most common medical conditions that affects men, especially elderly men. It has been reported that, in the United States, more than half of all men have histopathologic evidence of BPH by age 60 and, by age 85, approximately 9 out of 10 men suffer from the condition. Moreover, the incidence and prevalence of BPH is expected to increase as the average age of the population increases in developed countries.
[0006] The prostate gland enlarges throughout a man's life. In some men, the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This pressure on the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate. Thus, the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra. Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer. This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life. These symptoms include weak or intermittent urine flow while urinating, straining when urinating, hesitation before urine flow starts, feeling that the bladder has not emptied completely even after urination, dribbling at the end of urination or leakage afterward, increased frequency of urination particularly at night, urgent need to urinate, and the like.
[0007] In addition to patients with BPH, LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine,
chlorpheniramine, and the like) that cause urinary retention especially in men with prostate enlargement.
[0008] Although BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
[0009] In developed countries, a large percentage of the patient population undergoes treatment for BPH symptoms. It has been estimated that by the age of 80 years, approximately 25% of the male population of the United States will have undergone some form of BPH treatment. At present, the available treatment options for BPH include watchful waiting, medications (phytotherapy and prescription medications), surgery and minimally invasive procedures.
[0010] For patients who choose the watchful waiting option, no immediate treatment is provided to the patient, but the patient undergoes regular exams to monitor progression of the disease. This is usually done on patients that have minimal symptoms that are not especially bothersome.
[0011] Medications for treating BPH symptoms include phytotherapy and prescription medications. In phytotherapy, plant products such as Saw Palmetto, African Pygeum, Serenoa Repens (sago palm) and South African star grass are administered to the patient. Prescription medications are prescribed as first line therapy in patients with symptoms that are interfering with their daily activities. Two main classes of prescription medications are alpha-1 a-adrenergic receptors blockers and 5-alpha-reductase inhibitors. Alpha-1 a-adrenergic receptors blockers block the activity of alpha-1 a-adrenergic receptors that are responsible for causing constriction of smooth muscle cells in the prostate. Thus, blocking the activity of alpha-1 a-adrenergic receptors causes prostatic smooth muscle relaxation. This, in turn, reduces urethral resistance thereby reducing the severity of the symptoms. 5-alpha-reductase inhibitors block the conversion of testosterone to di-hydro-testosterone. Di-hydro-testosterone causes growth of epithelial cells in the prostate gland. Thus, 5-alpha-reductase inhibitors cause regression of epithelial cells in the prostate gland and, hence, reduce the volume of the prostate gland, which in turn reduces the severity of the symptoms.
[0012] Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
[0013] Transurethal Resection of Prostate (TURP) is the most commonly practiced surgical procedure implemented for the treatment of BPH. In this procedure, prostatic urethral obstruction is reduced by removing most of the prostatic urethra and a sizeable volume of the surrounding prostate gland. This is carried out under general or spinal anesthesia. In this procedure, a urologist visualizes the urethra by inserting a resectoscope, that houses an optical lens in communication with a video camera, into the urethra such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland. The distal region of the resectoscope consists of an electric cutting loop that can cut prostatic tissue when an electric current is applied to the device. An electric return pad is placed on the patient to close the cutting circuit. The electric cutting loop is used to scrape away tissue from the inside of the prostate gland. The tissue that is scraped away is flushed out of the urinary system using an irrigation fluid. Using a coagulation energy setting, the loop is also used to cauterize transected vessels during the operation.
[0014] Another example of a surgical procedure for treating BPH symptoms is Transurethral Electrovaporization of the Prostate (TVP). In this procedure, a part of prostatic tissue squeezing the urethra is desiccated or vaporized. This is carried out under general or spinal anesthesia. In this procedure, a resectoscope is inserted transurethrally such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland. The distal region of the resectoscope consists of a rollerball or a grooved roller electrode. A controlled amount of electric current is passed through the electrode. The surrounding tissue is rapidly heated up and vaporized to create a vaporized space. Thus, the region of the urethra that is blocked by the surrounding prostate gland is opened up.
[0015] Another example of a surgical procedure for treating BPH symptoms is Transurethral Incision of the Prostate (TUIP). In this procedure, the resistance to urine flow is reduced by making one or more incisions in the prostate gland in the region where the urethra meets the urinary bladder. This procedure is performed under general or spinal anesthesia. In this procedure, one or more incisions are made in the muscle of the bladder neck, which is the region
where the urethra meets the urinary bladder. The incisions are in most cases deep enough to cut the surrounding prostate gland tissue including the prostatic capsule. This releases any compression on the bladder neck and causes the bladder neck to spring apart. The incisions can be made using a resectoscope, laser beam, and the like.
[0016] Another example of a surgical procedure for treating BPH symptoms is Laser Prostatectomy. Two common techniques used for Laser Prostatectomy are Visual Laser Ablation of the Prostate (VLAP) and the Holmium Laser Resection/Enucleation of the Prostate (HoLEP). In VLAP, a neodymium: Yttrium-aluminum-gamet (NdYAG) laser is used to ablate tissue by causing coagulation necrosis. The procedure is performed under visual guidance. In HoLEP, a holmium: Yttrium-aluminum-gamet laser is used for direct contact ablation of tissue. Both these techniques are used to remove tissue obstructing the urethral passage to reduce the severity of BPH symptoms.
[0017] Another example of a surgical procedure for treating BPH symptoms is Photoselective Vaporization of the Prostate (PVP). In this procedure, laser energy is used to vaporize prostatic tissue to relieve obstruction to urine flow in the urethra. The type of laser used is the Potassium-Titanyl-Phosphate (KTP) laser. The wavelength of this laser is highly absorbed by oxyhemoglobin. This laser vaporizes cellular water and, hence, is used to remove tissue that is obstructing the urethra.
[0018] Another example of a surgical procedure for treating BPH symptoms is Open Prostatectomy. In this procedure, the prostate gland is surgically removed by an open surgery. This is done under general anesthesia. The prostate gland is removed through an incision in the lower abdomen or the perineum. The procedure is used mostly in patients that have a large (greater than approximately 100 grams) prostate gland.
[0019] Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
[0020] In Transurethral Microwave Thermotherapy (TUMT), microwave energy is used to generate heat that destroys hyperplastic prostate tissue. This procedure is performed under local anesthesia. In this procedure, a microwave antenna is inserted in the urethra. A rectal
thermosensing unit is inserted into the rectum to measure rectal temperature. Rectal temperature measurements are used to prevent overheating of the anatomical region. The microwave antenna is then used to deliver microwaves to lateral lobes of the prostate gland. The microwaves are absorbed as they pass through prostate tissue. This generates heat which in turn destroys the prostate tissue. The destruction of prostate tissue reduces the degree of squeezing of the urethra by the prostate gland, thus, reducing the severity of BPH symptoms.
[0021] Another example of a minimally invasive procedure for treating BPH symptoms is Transurethral Needle Ablation (TUNA). In this procedure, heat-induced coagulation necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using local anesthetic and intravenous or oral sedation. In this procedure, a delivery catheter is inserted into the urethra. The delivery catheter comprises two radiofrequency needles that emerge at an angle of 90 degrees from the delivery catheter. The two radiofrequency needles are aligned at an angle of 40 degrees to each other so that they penetrate the lateral lobes of the prostate. A radiofrequency current is delivered through the radiofrequency needles to heat the tissue of the lateral lobes to 70-100 degree Celsius at a radiofrequency power of approximately 456 KHz for approximately 4 minutes per lesion. This creates coagulation defects in the lateral lobes. The coagulation defects cause shrinkage of prostatic tissue which in turn reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
[0022] Another example of a minimally invasive procedure for treating BPH symptoms is Interstitial Laser Coagulation (ILC). In this procedure, laser-induced necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using regional anesthesia, spinal or epidural anesthesia or local anesthesia (periprostatic block). In this procedure, a cystoscope sheath is inserted into the urethra, and the region of the urethra surrounded by the prostate gland is inspected. A laser fiber is inserted into the urethra. The laser fiber has a sharp distal tip to facilitate the penetration of the laser scope into prostatic tissue. The distal tip of the laser fiber has a distal-diffusing region that distributes laser energy 360° along the terminal 3 mm of the laser fiber. The distal tip is inserted into the middle lobe of the prostate gland, and laser energy is delivered through the distal tip for a desired time. This heats the middle lobe and causes laser- induced necrosis of the tissue around the distal tip. Thereafter, the distal tip is withdrawn from the middle lobe. The same procedure of inserting the distal tip into a lobe and delivering laser
energy is repeated with the lateral lobes. This causes tissue necrosis in several regions of the prostate gland which, in turn, causes the prostate gland to shrink. Shrinkage of the prostate gland reduces the degree of squeezing of the urethra by the prostate, thus, reducing the severity of BPH symptoms.
[0023] Another example of a minimally invasive procedure for treating BPH symptoms is implanting Prostatic Stents. In this procedure, the region of urethra surrounded by the prostate is mechanically supported to reduce the constriction caused by an enlarged prostate. Prostatic stents are flexible devices that are expanded after their insertion in the urethra. They mechanically support the urethra by pushing the obstructing prostatic tissue away from the urethra. This reduces the constriction of the urethra and improves urine flow past the prostate gland thereby reducing the severity of BPH symptoms.
[0024] Although existing treatments provide some relief to the patient from symptoms of BPH, they have disadvantages. Alpha- 1 a-adrenergic receptors blockers have side effects such as dizziness, postural hypotension, lightheadedness, asthenia and nasal stuffiness. Retrograde ejaculation can also occur. 5-alpha-reductase inhibitors have minimal side effects, but only have a modest effect on BPH symptoms and the flow rate of urine. In addition, anti-androgens, such as 5-alpha-reductase, require months of therapy before LUTS improvements are observed. Surgical treatments of BPH carry a risk of complications including erectile dysfunction; retrograde ejaculation; urinary incontinence; complications related to anesthesia; damage to the penis or urethra; need for a repeat surgery; and the like. Even TURP, which is the gold standard in treatment of BPH, carries a high risk of complications. Adverse events associated with this procedure are reported to include retrograde ejaculation (65% of patients), post-operative irritation (15%), erectile dysfunction (10%), need for transfusion (8%), bladder neck constriction (7%), infection (6%), significant hematuria (6%), acute urinary retention (5%), need for secondary procedure (5%), and incontinence (3%). Typical recovery from TURP involves several days of inpatient hospital treatment with an indwelling urethral catheter, followed by several weeks in which obstructive symptoms are relieved, but there is pain or discomfort during micturition.
[0025] The reduction in the symptom score after minimally invasive procedures is not as large as the reduction in symptom score after TURP. Up to 25% of patients who receive these
minimally invasive procedures ultimately undergo a TURP within 2 years. The improvement in the symptom score generally does not occur immediately after the procedure. For example, it takes an average of one month for a patient to notice improvement in symptoms after TUMT and 1.5 months to notice improvement after ILC. In fact, symptoms are typically worse for these therapies that heat or cook tissue, because of the swelling and necrosis that occurs in the initial weeks following the procedures. Prostatic stents often offer more immediate relief from obstruction but are now rarely used because of high adverse effect rates. Stents have the risk of migration from the original implant site (up to 12.5% of patients), encrustation (up to 27.5%), incontinence (up to 3%), and recurrent pain and discomfort. In published studies, these adverse effects necessitated 8% to 47% of stents to be explanted. Overgrowth of tissue through the stent and complex stent geometries has made their removal quite difficult and invasive.
[0026] Thus, the most effective current methods of treating BPH carry a high risk of adverse effects. These methods and devices either require general or spinal anesthesia or have potential adverse effects that dictate that the procedures be performed in a surgical operating room, followed by a hospital stay for the patient. The methods of treating BPH that carry a lower risk of adverse effects are also associated with a lower reduction in the symptom score. While several of these procedures can be conducted with local analgesia in an office setting, the patient does not experience immediate relief and, in fact, often experiences worse symptoms for weeks after the procedure until the body begins to heal. Additionally, all device approaches require a urethral catheter placed in the bladder, and in some cases for weeks. In some cases, catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation. While drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
[0027] Cosmetic or Reconstructive Tissue Lifting and Repositioning:
[0028] Many cosmetic or reconstructive surgical procedures involve lifting, compressing or repositioning of natural tissue, natural tissue or artificial grafts, or aberrant tissue. For example, surgical procedures such as face lifts, brow lifts, neck lifts, tummy tucks, and the like, have become commonplace. In many cases, these procedures are performed by creating incisions through the skin, dissecting to a plane beneath muscles and fascia, freeing the muscles, fascia
and overlying skin from underlying structures (e.g., bone or other muscles), lifting or repositioning the freed muscles, fascia and overlying skin, and then attaching the repositioned tissues to underlying or nearby structures (e.g., bone, periostium, or other muscles) to hold the repositioned tissues in their new (e.g., lifted) position. In some cases, excess skin may also be removed during the procedure.
[0029] There have been attempts to develop minimally invasive devices and methods for cosmetic lifting and repositioning of tissues. For example, connector suspension lifts have been developed where one end of a standard or modified connector thread is attached to muscle and the other end is anchored to bone, periostium or another structure to lift and reposition the tissues as desired. Some of these connector suspension techniques have been performed through cannulas or needles inserted though relatively small incisions of puncture wounds.
[0030] There remains a need for the development of a suture lock or suture anchor that can be used throughout the bodyThe disclosed embodiments address these and other needs.
SUMMARY
[0031] Briefly and in general terms, the present disclosure is directed towards a slotted suture anchor which includes a back end that resembles a flattened tube in shape, with a width in lateral cross-section that is greater than its thickness. The slotted suture anchor also includes a pair of spaced apart prongs. The spaced prongs join together at a slot inception. The prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs. The mechanism of suture attachment and strength of the assembly is a combination of compression of the suture between the stiff slotted prongs of the anchor as well as disruption of the suture surface by the discreet edges of the slotted, flattened-tubular anchor. The discreet edges provide a lower contact surface area between anchor prongs and suture and focuses the compressive forces in focal points that cause the suture to conform around both internal recesses and external faces. In some embodiments, the prongs include inwardly facing protrusions that are configured to capture and deform the suture between the protrusions and prevent the suture from disengaging from the slotted anchor device once engaged.
[0032] Various further embodiments of slotted anchors are also contemplated. In each, a pair of rigid prongs are provided so that a grip onto a connector can be achieved without the necessity or significant reliance upon an additional locking member. In particular, various embodiments of slotted structures are disclosed which accordingly provide alternative approaches to inward extending protrusions as well as the slot inception of the device.
[0033] Other features and advantages will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate by way of example, the features of the various embodiments.
BRIEF DESCRIPTION OF THE DRAWINGS
[0034] FIG. 1 is a perspective view of one embodiment of an anchor assembly that includes a distal anchor and a proximal anchor secured together by a suture;
[0035] FIG. 2 is a top view of one embodiment of a slotted anchor;
[0036] FIG. 3 A is a cross section of the suture and the slotted anchor assembly taken along lines 3 A-3 A of FIG. 1;
[0037] FIG. 3B is a cross section of the anchor assembly taken along lines 3B-3B of FIG. 1;
[0038] FIG. 4 is a close up perspective view of the slot inception, wider seating region, and inwardly facing protrusions of the slotted anchor of FIG. 2;
[0039] FIG. 5 is a perspective view of another embodiment of a slotted anchor; [0040] FIG. 6 is top view of the slotted anchor of FIG. 5;
[0041] FIG. 7 is a close up perspective view of the slot inception, wider seating region, and inwardly facing protrusions of the slotted anchor of FIG. 5;
[0042] FIG. 8 is a perspective view of the distal anchor with a orthogonally oriented tail portion;
[0043] FIG. 9 is a side view of the distal anchor with a orthogonally oriented tail portion of FIG. 8 and the suture in an in-line configuration;
[0044] FIG. 10 is a cross sectional view of an anchor assembly of FIG. 1 implanted through the prostate of an individual with benign prostatic hyperplasia;
[0045] FIG. 11 is a perspective view of a slotted anchor; [0046] FIG. 12 is a top view of the slotted anchor of FIG. 11;
[0047] FIG. 13 is a perspective view of a slotted anchor having tapered prongs that converge towards a circular seating region before the slot inception;
[0048] FIG. 14 is a top view of the slotted anchor of FIG. 13;
[0049] FIG. 15 is a perspective view of a slotted anchor having tapered prongs that converge towards a serrated seating region before the slot inception;
[0050] FIG. 16 is a close up top view of the slotted anchor of FIG. 15;
[0051] FIG. 17 is a perspective view of a slotted anchor having tapered prongs that converge towards a barbed seating region before the slot inception;
[0052] FIG. 18 is a close up top view of the slotted anchor of FIG. 17;
[0053] FIG. 19 is a perspective view of a slotted anchor having a tubular shape and tapered prongs that converge towards inwardly facing protrusions in the seating region before the slot inception;
[0054] FIG. 20 is a side view of the slotted anchor of FIG. 19; [0055] FIG. 21 is an end view of the slotted anchor of FIG. 19;
[0056] FIG. 22 is a top view of a slotted anchor having prongs that begin a tapered convergence before turning parallel towards a triple-barbed slot inception;
[0057] FIG. 23 is a close up perspective view of the top layer of the slotted anchor of FIG.
22;
[0058] FIG. 24 is a top view of a slotted anchor having prongs that begin a tapered convergence before turning parallel towards a circular slot inception;
[0059] FIG. 25 is a close up perspective view of the top layer of the slotted anchor of FIG.
24;
[0060] FIG. 26 is a perspective view of an unfolded slotted anchor, wherein one side of the anchor has an inwardly protruding seating region that is an inverted configuration from the other side of the inwardly protruding seating region of the anchor;
[0061] FIG. 27 is a perspective view of the folded slotted anchor of FIG. 26; [0062] FIG. 28 is a top view of the folded slotted anchor of FIG. 26;
[0063] FIG. 29 is a perspective view of an unfolded slotted anchor having oppositely tapered prongs that converge towards the oblong slot inception;
[0064] FIG. 30 is a top view of the folded slotted anchor of FIG. 29;
[0065] FIG. 31 is a perspective view of a slotted anchor having a slit in its top along its length;
[0066] FIG. 32 is a top view of the slotted anchor of FIG. 31;
[0067] FIG. 33 is a cross-sectional view of the slotted anchor of FIG. 31 taken along line 33- 33 of FIG. 32;
[0068] FIG. 34 is a perspective view of a slotted anchor having a slit in its side along its length;
[0069] FIG. 35 is a top view of the slotted anchor of FIG. 34;
[0070] FIG. 36 is a cross-sectional view of the slotted anchor of FIG. 34 taken along line 36- 36 of FIG. 35;
[0071] FIG. 37 is a perspective view of a slotted anchor wherein the top half of the anchor has an inverted configuration from the bottom of the anchor to create three slots of intersection with the suture;
[0072] FIG. 38 is an end view of the slotted anchor of FIG. 37;
[0073] FIG. 39 is a perspective view of a slotted anchor that is substantially square in cross- section, but is otherwise similar to the slotted anchor of FIG. 4;
[0074] FIG. 40 is a top view of a slotted anchor that incorporates a slit along its top, and is formed into a substantially square shaped member in cross-section that is folded over on itself towards its center
[0075] FIG. 41 is a cross-sectional view of the slotted anchor of FIG. 40; [0076] FIG. 42 is a perspective view of the slotted anchor of FIG. 40;
[0077] FIG. 43 is a perspective view of a slotted anchor that incorporates a slit along its top and has one prong with a shorter height than the other prong;
[0078] FIG. 44 is a cross-sectional view of the slotted anchor of FIG. 43;
[0079] FIG. 45 is a cross-sectional, perspective view of the slotted anchor of FIG. 43.
DETAILED DESCRIPTION
[0080] Turning now to the figures, which are provided by way of example and not limitation, the disclosed embodiments are illustrated with regard to anchor assemblies configured to be delivered within a patient's body. As stated, the disclosed embodiments can be employed for various medical purposes including but not limited to approximating, retracting, lifting, compressing, supporting or repositioning tissues, organs, anatomical structures, grafts or other material found within a patient's body. Such tissue manipulation is intended to facilitate the treatment of diseases or disorders. Moreover, the disclosed embodiments have applications in cosmetic or reconstruction purposes, or in areas relating to the development or research of medical treatments. Referring now to the drawings, wherein like reference numerals denote like or corresponding components throughout the drawings and, more particularly to FIGS. 1-7, there is shown an embodiment of an anchor assembly .
[0081] In such applications, one portion of an anchor assembly is positioned and implanted against a first section of anatomy. A second portion of the anchor assembly is then positioned and implanted adjacent to a second section of anatomy for the purpose of approximating, retracting, lifting, compressing, supporting or repositioning one section of anatomy with respect to the other section of anatomy, as well as for the purpose of approximating, retracting, lifting, compressing, supporting or repositioning one section of anatomy with respect to the other section of anatomy. It is also to be recognized that both a first and second portion of the anchor assembly can be configured to accomplish the desired approximating, retracting, lifting, compressing, supporting or repositioning of anatomy due to tension supplied thereto via a connector assembly (e.g., suture) affixed to the first and second portions of the anchor assembly.
[0082] In one embodiment of the anchor assembly, the anchor assembly is configured to include structure that is capable of being implanted within a patient's body. The anchor assembly may also be used in conjunction with a conventional remote viewing device (e.g., an endoscope) so that an interventional site can be observed.
[0083] In one embodiment, the anchor assembly can be placed at an intervention site using a delivery tool (See co-pending U.S. Application No. 11/318,240). One specific, non-limiting application of the delivery tool is for the treatment of benign prostatic hyperplasia. In this
procedure, an implant is delivered to a prostatic lobe that is obstructing the urethral opening and restricting flow. The implant compresses the lobe, thereby increasing the urethral opening and reducing the fluid obstruction through the prostatic urethra.
[0084] Additionally, in one embodiment, the anchor assembly is embodied in a tissue approximation anchor (TAA). The tissue approximation anchor is an implant assembly that includes one tubular member, referred to as the capsular anchor or, more generally, distal anchor 70. The distal anchor 70 is preferably connected by a suture (preferably polyester) 78 to a slotted, flattened-tubular member (preferably comprised of stainless steel), referred to as the urethral anchor or proximal anchor 84. In one specific, non-limiting embodiment, the distal anchor 70 is comprised of an electro-polished Nitinol (nickel titanium alloy SE508, 50.8% nickel) tube.
[0085] The tissue approximation anchor is designed to be useable in an office environment (in contrast to requiring a hospital environment) with a delivery tool. The delivery tool is used through a 19 Fr sheath in one preferred embodiment, while in another embodiment a sheath size of 2 IF is employed. Additionally, the material selection and construction of the tissue approximation anchor still allows for a subsequent TURP procedure to be performed, if necessary, on the prostate. In this suture-based, tissue approximation technique, a needle delivery mechanism (as described in U.S. Application No. 11/318,246) is used to implant a nitinol distal anchor 70 and attached suture 78. Once the distal anchor 70 and attached suture 78 have been deployed, with the needle retracted and the suture 78 tensioned, the slotted anchor 84 is pushed by the delivery tool and captures the suture 78 transverse to the anchor axis. The flattened portion of the anchor 84 allows the anchor to be held by the tool without rotating so that it will stay oriented properly to ensure the suture enters the space between the prongs. In many of the illustrated embodiments, the seating region in the slotted anchor for the suture is shown in approximately the midpoint of the slotted anchor but it is within the scope of the present invention to locate the seating region closer to one end or the other of the anchor in order to prevent the ends of the prongs of the anchor from digging into tissue after implantation but rather sit more parallel to the tissue, if so desired.
[0086] In one embodiment, the nitinol tube is attached to a USP size 0 PET (Poly Ethylene Terephthalate) monofilament suture 78 by thermally forming the suture to locking features on
the anchor 70. Referring again to the suture itself, the PET suture is a round monofilament extrusion / pulltrusion composed of a grade 8816 polyethylene terephthalate. Typically, the base material for the suture is annealed at approximately 100 degrees Celsius for approximately 130 minutes in a straight condition. In one non-limiting embodiment, the PET suture 78 has a diameter of 0.015 inches and a tensile strength greater than or equal to 12.7 pounds.
[0087] In one embodiment, the anchor 84 is a 316L stainless steel flattened tube that is slotted, electro-polished, and passivated. The anchor is depicted in the figures with a flat surface on the top or bottom but it is within the scope of the present invention that only one of the surfaces be flat and that the surface(s) do not have to be true flat but rather could have a slight dip or protrusion on the flattened surfaces. The slotted anchor 84 includes prongs 96 that grip and deform the suture 78 in the seating region 98 between the spaced prongs 96. It is to be recognized that rather than defining mirrored images, in one or more of the embodiments disclosed herein, the seating region can be formed by staggered structure or one prong can have a longer area defining seating structure than an opposing prong to provide an effective engagement for a particular suture or connector design. The prongs 96 are quite stiff and robust therefore subject to minimal to no deflection. In particular preferred embodiments, the prongs or overall width of the anchor adjacent the seating region 98 expands, after a connector has been seated in the seating region, less than about 0.002 inches (i.e., less than about five percent), more preferably less than about .001 inches (i.e., less than about two and half percent). In particular preferred embodiments, the prongs or overall width of the anchor adjacent the ends of the prongs 96 expands, after a connector has been seated in the seating region, less than about 0.0065 inches (i.e., less than about seventeen percent), more preferably less than about .006 inches (i.e., less than about fifteen percent). Due to its particular configuration, the slotted anchor 84 also requires less force to deploy onto a suture 78. Being relatively stiff, the prongs 96 of the slotted anchor 84 are significantly more resistant to bending. The four individual edges/faces (two on each prong 96) of the slotted anchor 84 disrupt the surface of the suture 78, both biting into the suture 78 as well as compressing the suture 78 between the slotted prongs 96, including sometimes melting the suture locally due to the pressure and heat created during deployment of the slotted anchor onto the suture. The reduced area of contact provided by this structure as well as multiple planes of engagement of the anchor slot to the connector strengthens connections and prevents inadvertent separation. Additionally, the narrow width of the slot inception 97 is
substantially smaller than the connector diameter, with the purpose to allow the stiffer prongs to slightly elastically expand over the connector and contribute to anchor retention by means of compression but not intended to receive the connector into this relief slot, which is positioned proximal to the seating portion 98. It is beneficial in some circumstances however for the slotted anchor to be pushed far enough on to the connector such that the connector becomes at least partially seated in the slot inception relief slot so that it becomes pinched and/or wedged. In this circumstance, a two-part compression slot is created wherein the short, narrow part of the slot ensures a good mechanical interlock but my compromise the strength of the suture locally and the second wider part is ensures a good mechanical interlock but without any compromise in the strength of the suture. Notably, the outwardly stepped slot width also has a dimension smaller than the connector diameter, and receives the connector with some interference.
[0088] In one embodiment, the prongs 96 are formed from a wide (or flattened) tubular structure. The wider and smoother prongs 96 of the anchor 84 assist in preventing the prongs 96 from irritating and/or damaging tissue, which is more likely to occur with a thinner and pointier leg structure forming piercing structure. Further, in one embodiment, the slot in the anchor 84 is configured to create registering and aligning surfaces to the delivery tool (not shown). In several embodiments, the two inner surfaces of the prongs 96 of the slotted anchor 84 are configured as corresponding inwardly facing U-shapes. In this configuration, the inner surfaces of the prongs 96 bite into the suture 78. In still other embodiments, the two inner surfaces of the prongs 96 of the slotted anchor 84 are configured to present a notched geometry. In still other embodiments, the inner surfaces of the prongs are configured with burrs, roughened edges, serrations, etc. to enhance their ability to retain the connector.
[0089] In several embodiments, such as for example figures 1-7, the slotted anchor 84 includes a rigid generally tubular or flattened cylindrical back end 95, extending from which are a pair of spaced prongs 96. Optionally, the anchor assembly may be filled in with a radiopaque material, or other therapeutic agent. Terminal ends of the prongs 96 may be tapered to receive a section of the suture 78. Notably, the prong structure commences at a narrowed slot inception 97, which steps outwardly to a wider dimension to thereby define the space between the prongs 96. This narrow slot 97 provides the slotted anchor 84 with desired structural rigidity to receive the suture 78 and to facilitate locking engagement with the slotted anchor 84. Notably, the
space between the prongs 96 of the slotted anchor 84 is dimensioned relative to the diameter of the suture 78 such that is has sufficient gripping force moving toward the seating region 98 to obviate the need for a securing end unit. Accordingly, in a preferred embodiment, a securing end unit is not needed. Moreover, it is to be recognized that the slot inception 97 is not intended to receive a connector or suture 78 but rather it provides the prongs with the slight flexibility to receive the suture 78 in a manner so that the suture 78 is positioned as desired within the seating region. Such desired positioning creates a lock between the anchor 84 and the suture 78 thereby providing the clinical benefit of preventing loss of tension between members forming an anchor assembly.
[0090] As described above, in one embodiment, shaped tube raw stock is used to produce the anchor 70 and the anchor 84 using slot/profile cutting. Specifically, in one embodiment the raw stock may be cut by laser, wire-EDM, or stamped from a flat and formed into a shape. In one non-limiting embodiment, the raw stock has a total height ranging from 0.020 inches to 0.025 inches, and has a total width ranging from 0.038 inches to 0.040 inches. Thus, this raw stock is flatter and wider than a purely round tube would be.
[0091] The inwardly facing protrusion region 99 on the prongs 96 is configured to keep the suture 78 from "walking" out over time. In one embodiment, the inner surface of the prongs 96 near the slot inception 97 is more of an extended landing (i.e., wider seating region 98) than a simple U-shaped surface configuration. Various of the contemplated embodiments can include such landings and the landings can assume curved or other shapes. Additionally, the inner surface of the prongs 96 can have alternative configurations differing from a U-shape. Non-flat inner surfaces tend to facilitate retention of a suture 78 under tension such as exemplified in FIG. 3B which depicts a suture forming a hourglass shape between opposing surfaces of prongs 96. The outer surfaces of the prongs 96 are contemplated to define an atraumatic structure such as that provided by curved surfaces. In one embodiment, there is a longer root diameter for better seating of the suture 78. In such an embodiment, the prongs 96 have a straight lead-in initially before beginning to taper. In another embodiment (See FIGS. 5 and 6), the prongs have a tapered lead-in configuration with additional inward protrusions 100. This tapered lead-in configuration with additional inward protrusions 100 assists with the centering of the suture 78 into the seating region 98 and facilitated placement of the anchor onto the suture 78.
[0092] In one embodiment, a 0.014 inch gap between prongs 96 provides a structure suitable for use with a 0.015 inch suture 78 while allowing minimal to no tissue impingement. In another approach, the seating region 98 of the slot has a 0.008 inch gap while the inwardly protruding region 99, which helps prevent a suture 78 from walking out over time, has a 0.006 inch gap. In still another embodiment, the seating region 98 of the slot has a 0.009 inch gap, while the inwardly protruding region 99, has a 0.007 inch gap. In one embodiment, seating region 98 is approximately 0.011 inches.
[0093] These configurations create a lower resistance interference fit to achieve reliable seating while maintaining strength. It will be appreciated by those skilled in the art, that many variations in the slot parameters are possible for optimizing performance in different situations. Additionally, in some embodiments, the protrusions formed on opposite prongs may be of differing shapes. Such slot parameters include, by way of example only, and not by way of limitation: width, thickness, length, and profile.
[0094] One embodiment of an anchor assembly 10 is depicted in FIGS. 8-10. In its unconstrained configuration, the anchor 70 includes a tubular (head) portion 72 which is generally orthogonally oriented to a tail portion 74. It is to be noted, however, that while housed in a delivery assembly and prior to deployment at a target area, the anchor 70 is constrained to define a generally straight configuration, only subsequently assuming the unconstrained (i.e., orthogonally oriented) configuration upon deployment from a delivery device.
[0095] The anchor 70 is laser cut or wire EDM (electrical discharge machined) from a Nitinol base stock that is generally-tubular in shape. The nitinol anchor is shape-set to have a "flipping tail" and is electro-polished. The suture 78 is then attached to the anchor 70. Specifically, in one embodiment, the PET suture 78 is thermoformed onto locking features in the anchor 70. The anchor 70 may be locally heated to re-flow the suture onto the end of the anchor 70 and into cutouts on the anchor 70. Continuing, in one non-limiting embodiment, the post electro-polished anchor 70 has a 0.016 inner diameter and a 0.0245 outer diameter.
[0096] In one non- limiting embodiment, the tubular portion 72 of the anchor 70 includes a plurality of tabs 76 which can be deformed or deflected to accomplish affixing the anchor 70 to a suture 78. It has been found that three such tabs 76, two on one side of the tubular portion 72 and one on an opposite side, provide a sufficient connecting force. However, the anchor 70 may
be attached to the suture 78 through any of several known techniques, such as by being attached to the distal end of the tubular portion 72.
[0097] In another aspect of a non-limiting embodiment, it is contemplated that the anchor 70 can be laser cut from a tube formed of Nitinol or other appropriate material. A mid-section 80 of the distal anchor 70 provides a structural transition from the tubular portion 72 to the tail portion 74. As such, a portion of a side wall is removed in the mid-section area 80. A further portion of the side wall is removed to define a connector section 82 of the tail 74 which extends from the mid-section 80. In one embodiment, this connector section 82 includes a bend that creates the orthogonally or obliquely oriented configuration. This connector section 82 acts as a barb or deflected strut to cause rotation of the anchor 70 relative to the suture 78 after deployment from a delivery tool (creating a "flipping tail") and produce the relative unconstrained (orthogonally oriented) angle assumed between the tail 74 and tubular portion 72 of the anchor 70. The recovered shape of the terminal end portion 83 of the anchor presents a transverse strut that engages tissue when the suture is tensioned.
[0098] Thus, in its implanted form (FIG. 1), the anchor assembly can include an anchor 70 (e.g., first anchor) whose initial engagement with a suture 78 is generally coaxial, and an anchor 84 (e.g., second anchor) with an initial engagement being generally perpendicular with the suture 78. The anchor 70 is "unsheathed" from a needle delivery device (not shown) once positioned for reliable deployment An anchor assembly ejected from a terminal end of a delivery device and implanted across a prostate is shown in FIG. 10.
[0099] A number of additional embodiments of the slotted anchor aredescribed. It is to be recognized that the previous and below disclosed structures can be used for many applications. However, each of these disclosed embodiments may include structure accomplishing an engagement with a connector without requiring a secondary locking component. Such a secure engagement can be provided by an interference between anchor structure and the connector resulting in deformation of the connector.
[00100] Referring now to FIGS. 11-12, an embodiment of a slotted anchor 1184 having a flattened tubular shape is shown. In this embodiment, the slotted anchor 1184 has a width in lateral cross-section that is greater than its thickness, as well as tapered prongs 1196 that meet at a circular slot inception 1197 after passing inwardly facing protrusions 1199 and a seating
region 1198 for the suture 78. This embodiment lacks a "relief slot" at the slot inception 1197 (as shown in FIGS. 5-7), but instead has only the above-described circular seating region 1198 for receiving the suture 78.
[00101] FIGS. 13-14 illustrate an embodiment of a slotted anchor 1384 having a flattened tubular shape. In this embodiment, the slotted proximal anchor 1384 has a width in lateral cross- section that is greater than its thickness. The anchor further includes tapered prongs 1396 that converge towards a circular seating region 1398 after passing inwardly facing protrusions 1399 and before reaching a generally U-shaped, more narrowly dimensioned slot inception 1397. This embodiment includes a "relief slot" at the slot inception 1397 for receiving the suture 78. Additionally, the relief slot may reduce stress concentration in the anchor when the suture is seated.
[00102] Referring now to FIGS. 15-16, an embodiment of a slotted anchor 1584 also having a flattened tubular shape is shown. In this embodiment, the slotted anchor 1584 includes tapered prongs 1596 that converge towards a seating region 1598 after passing a plurality of inwardly facing serrated protrusions 1599 and before the slot inception 1597. Here, as the serrated region 1599 tapers towards the seating region 1598, the surfaces forming apices of the serrated region have generally equal dimensions. It is also to be recognized that the serrated region 1599 can also define or embody a portion of a seating region. The serrated region 1599 can function to lock into and grasp a connector to thereby result in a firm engagement as well as provide a lower surface area for contacting a suture being placed therethrough. The apices of the serrated region cause more deformation than many of the previously discussed surfaces without abrading the suture 78.
[00103] Another embodiment of a slotted anchor 1784 having a flattened tubular shape and a serrated region is shown in FIGS. 17-18. In this embodiment, tapered prongs 1796 converge towards a seating region 1798 extending from a slot inception 1797 after passing a serrated region formed by inwardly facing barbed protrusions 1799. The barbed protrusions 1799 of the serrated region are formed by surfaces of different dimensions, thus forming more of a barbed shape. Such a barbed shape is intended to facilitate sufficient gripping forces on a suture 78. A slotted proximal anchor 1784 with a barbed serrated region preferably is used in conjunction with a tougher type of suture 78 that is resistant to abrasion.
[00104] Referring now to FIGS. 19-21, yet a further embodiment of a slotted anchor 1984 having a tubular shape is shown. In this embodiment, the slotted proximal anchor 1984 has tapered prongs 1996 that converge toward inwardly facing protrusions 1999 adjacent the seating region 1998 before reaching the slot inception 1997. In combination, the angle formed by the tapered prongs, the protrusion and relatively narrow dimension of the seating region cooperate to create a substantial engagement with a connector. Preferably, the protrusions 1999 cause moderate deformation of the suture 78 while minimizing abrasion of the suture.
[00105] FIGS. 22-23 show an embodiment of a slotted anchor 2284 having a generally rectangular shape and that has been formed by stamping a flat sheet of metal that is folded over at the leading end of the prongs 2296 to form two layers (only one layer is shown). In this embodiment, the slotted anchor 2284 has a width in lateral cross-section that is greater than its thickness. The anchor also includes prongs 2296 that define a tapered convergence before turning parallel towards inwardly facing barbed protrusions 2299, one projecting from each prong. The anchor also includes a seating region 2298 configured adjacent a barbed slot inception 2297. The barbed slot inception 2297 and barbed protrusions 2299 cooperate to deform and grasp a suture 78. Preferably, these barbed protrusions create more point pressure or "bite" into the suture 78and therefore is contemplated to be used in conjunction with a tougher type of suture 78 that is more resistant to abrasion.
[00106] Referring now to FIGS. 24-25, there is shown another embodiment of a slotted anchor 2484 having a generally rectangular portion that has been formed by folding over a flat sheet (only one layer is shown). In this approach, the slotted proximal anchor 2484 has a width in lateral cross-section that is greater than its thickness transverse to the axis of the suture 78, and prongs 2496 that begin a tapered convergence before turning parallel towards a seating region 2498 formed at a circular slot inception 2497. This circular slot inception 2497 creates a compression ring to secure the suture 78. This type of compression ring tends to deform the suture 78 without abrading the suture 78 (i.e., less "bite" into the suture). This embodiment also has expanded width prongs 2496. In this manner, the terminal ends of the prongs 2496 diverge in a manner such that they span a dimension greater than the width of the rectangular portion. Such structure facilitates receiving the connector and guides it to the seating region 2498 as the anchor 2484 is moved into engagement with the suture.
[00107] As shown in FIGS. 26-28, and as best seen in FIG. 27, another embodiment of a slotted anchor 2684 has tapered prongs 2696 that converge toward inward protrusions 2699 and a seating region 2698 before reaching the circular slot inception 2697. This anchor 2684 can be formed by stamping or cutting of flat metal stock to produce an elongated member and then folding the member in half. When folded, the pattern formed into the structure defines the inward protrusions 2699, seating region 2698, and circular slot inception 2697. Otherwise stated, in this embodiment, one side of the anchor 2684 has inward protrusions 2699 that are an inverted configuration from the inward protrusions 2699 on the other side of the anchor 2684 to form structure well suited to grip a connector. This embodiment has an oblong seating region 2698 for receiving the suture 78. After the elongated member is folded, a unitary body may be produced by tack welding or laser welding the anchor 2684 together. This type of slotted anchor 2684 is generally easier to manufacture.
[00108] Referring now to FIGS. 29-30, another embodiment of a slotted anchor 2984 formed from a folded member is shown. In this approach, when folded, the slotted proximal anchor 2984 has a width in lateral cross-section that is greater than its thickness and oppositely tapered prongs 2996 that converge toward inward protrusions 2999 and a seating region 2998 before reaching the slot inception 2997. Additionally, in this embodiment one side of the anchor 2984 has oppositely tapered prongs 2996 that are an inverted configuration from the other side of the oppositely tapered prongs 2996 of the anchor 2984. This embodiment has an oblong seating region 2998 for receiving the suture 78.
[00109] FIGS. 31-33 depict an embodiment of a slotted anchor 3184 having a slit that extends along its top. This anchor is produced using an alternative forming technique, namely the flat sheet is rolled along its length rather than being folded at its ends as described before. Thus, in cross-section the anchor defines a C-shape (See FIG. 33). In this embodiment, the slotted anchor 3184 again has a width in lateral cross-section that is greater than its thickness and includes tapered prongs 3196. The prongs 3196 converge toward inward protrusions 3199 and continue to a circular seating region 3198 before reaching the slot inception 3197. Additionally, in this embodiment the prongs 3196 include inwardly facing protrusions at their terminal ends that increase the stiffness of the prongs 3196, as well as reducing possible irritation of the surrounding tissue when implanted. If desired, during manufacturing, the anchor 3184 can be
clamped down to close the slit that extends along its length. As described above, a unitary body may be produced by tack welding or laser welding the anchor 2984 together in some embodiments.
[00110] Referring now to FIGS. 34-36, an embodiment of a slotted anchor 3484 having a slit extending along the outside wall of one of the prongs 3496. Here, a cross-section of the anchor 3484 defines a U shape (See FIG. 36). In this embodiment, the slotted anchor 3484 has a width in lateral cross-section that is greater than its thickness and tapered prongs 3496 that converge toward inward protrusions 3499 and a circular seating region 3498. The circular seating region 3498 is configured adjacent a slot inception 3497. Additionally, the prongs 3496 include inwardly facing protrusions at their terminal ends.
[00111] In still another embodiment, a slotted anchor 3784 that is formed from an S-shaped folded member is depicted in FIGS. 37-38. In this embodiment, the slotted anchor 3784 includes structure forming tapered prongs 3796 that converge towards a semi-circular seating region 3798 formed adjacent the slot inception 3797. Additionally, in this embodiment the top half of anchor 3784 has an inverted configuration from the bottom of the anchor 3784 to create multiple places capable of intersecting with a suture. In this embodiment, the prongs 3196 generate three layers for gripping the suture. It is within the scope of the present invention to provide multiple layers of engagement with the suture.
[00112] Referring now to FIG. 39, an embodiment of a slotted anchor 3984 is shown. The slotted anchor 3984 is quite similar to the slotted anchor 84 shown in FIG. 4, except that the slotted anchor 3984 of FIG. 39 is substantially square in cross-section. Additionally, the prongs 3996 of the slotted anchor 3984 are significantly shorter than the prongs 96 of the slotted anchor 84 shown in FIG. 4. This embodiment includes a "relief slot" at the slot inception 3997and a seating region 3998.
[00113] In another embodiment depicted in FIGS. 40-42, a slotted anchor 4084 incorporates a slit in its top, and is formed into a substantially square shaped member that is folded over on itself towards its center. This "folded over" region produces a greater surface area that is in contact with the suture 78, and thus, creates a larger amount of deformation of the suture 78 and friction against the suture 78. In this embodiment, the slotted anchor 4084 includes a structure
forming tapered prongs 4096 that converge towards protrusions 4099 and a seating region 4098 formed adjacent to the slot inception 4097.
[00114] In yet another embodiment shown in FIGS. 43-45, a slotted anchor 4384 incorporates a slit in its top, and has one prong 4396 with a shorter height than the other prong. In this embodiment, the slotted anchor 4384 includes structure forming tapered prongs 4396 that converge towards inward protrusions 4399 and seating region 4398 formed adjacent the slot inception 4397. This anchor's configuration, which incorporates one prong 4396 with a shorter height than the other prong, creates multiple places at different heights capable of intersecting with a suture 78. In this embodiment, the prongs 4396 generate less distortion of the suture 78, but more friction against the suture.
[00115] The disclosed embodiments contemplate both pushing directly on anchor portions of an anchor assembly as well as pushing directly upon the connector of the anchor assembly. Further, an anchor assembly can be delivered and deployed at an interventional site by a deployment device. Consequently, in the context of prostate treatment, the disclosed embodiments accomplish both compressing of the prostate gland and the opening of the prostatic urethra and applying tension between ends of the implant. Moreover, drug delivery is contemplated as a further remedy in BPH and over-active bladder treatment.
[00116] Once implanted, the anchor assembly of the disclosed embodiments accomplishes desired tissue approximation, manipulation, compression or retraction, as well as cooperates with the target anatomy to provide an atraumatic support structure. In particular, the shape and contour of the anchor assembly can be configured so that the assembly invaginates within target tissue, such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly. In fact, in situations where the anchor assembly is properly placed, wispy or pillowy tissue in the area collapses around the anchor structure. Eventually, the natural tissue can grow over the anchor assembly, and new cell growth occurs over time. Such cooperation with target tissue facilitates healing and avoids unwanted side effects such as calcification or infection at the interventional site.
[00117] Furthermore, in addition to an intention to cooperate with natural tissue anatomy, the disclosed embodiments also contemplate approaches to accelerate healing or induce scarring.
Manners in which healing can be promoted can include employing abrasive materials, textured connectors, biologies and drugs.
[00118] It has been observed that placing the anchors at various desired positions within the anatomy can extract the best results. For example, when treating a prostate, one portion of an anchor can be placed within a urethra. It has been found that configuring such anchors so that ten o'clock and two o'clock positions (when looking along the axis of the urethra) are supported or retained, effectively holds the anatomy open and also can facilitate invagination of the anchor portion within natural tissue. This is particularly true in the regions of anatomy near the bladder and the juncture at which the ejaculatory duct connects to the urethra.
[00119] Moreover, it is to be recognized that the foregoing procedure is reversible. In one approach, the connection of an anchor assembly can be severed and a proximal (or second) anchor component removed from the patient's body. For example, the physician can simply cut the connector and simultaneously remove the second anchor previously implanted for example, in the patient's urethra. It is to be recognized that various materials are contemplated for manufacturing the disclosed devices. Moreover, one or more components such as distal anchor 70, proximal anchor 84, suture 78, of the one or more anchor assemblies disclosed herein may be designed to be completely or partially biodegradable or bio-fragmentable.
[00120] Further, as stated, the systems and methods disclosed herein may be used to treat a variety of pathologies in a variety of tubular structures comprising a cavity or a wall. Examples of such organs include, but are not limited to urethra, bowel, stomach, esophagus, trachea, bronchii, bronchial passageways, veins (e.g. for treating varicose veins or valvular insufficiency), arteries, lymphatic vessels, ureters, bladder, cardiac atria or ventricles, uterus, fallopian tubes, and the like.
[00121] Finally, it is to be appreciated that the invention has been described hereabove with reference to certain examples or embodiments, but that various additions, deletions, alterations and modifications may be made to those examples and embodiments without departing from the intended spirit and scope of the disclosed embodiments. For example, any element or attribute of one embodiment or example may be incorporated into or used with another embodiment or example, unless to do so would render the embodiment or example unpatentable or unsuitable for its intended use. Also, for example, where the steps of a method are described or listed in a
particular order, the order of such steps may be changed unless to do so would render the method unpatentable or unsuitable for its intended use. All reasonable additions, deletions, modifications and alterations are to be considered equivalents of the described examples and embodiments and are to be included within the scope of the following claims.
[00122] The various embodiments described above are provided by way of illustration only and should not be construed to limit the disclosed embodiments. Those skilled in the art will readily recognize various modifications and changes that may be made to the disclosed embodiments without following the example embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the disclosed embodiments, which is set forth in the following claims.
Claims
1. A slotted anchor for securing a connector, comprising: a back end; and at least two spaced prongs extending from a slot inception, and wherein the prongs are shaped, sized and of a rigidity to substantially prevent deflection of the prongs; wherein the prongs include inwardly facing surfaces that are configured to capture the connector between the protrusions and prevent the connector from disengaging the slotted anchor once engaged.
2. The slotted anchor of claim 1 , wherein inner surfaces of the prongs near the slot inception have a plurality of edges of engagement with the connector in use.
3. The slotted anchor of claim 1, wherein terminating ends of the prongs are tapered inwardly to facilitate receiving a section of the connector.
4. The slotted anchor of claim 1, wherein the spaced prongs commence at a slot inception that steps outwardly to a wider dimension, thereby defining a space between the prongs.
5. The slotted anchor of claim 4, wherein the space between the prongs of the slotted anchor has a dimensional interference, relative to the diameter of the connector.
6. The slotted anchor of claim 1, wherein the inwardly facing surfaces are protrusions comprising serrated teeth.
7. The slotted anchor of claim 1, wherein the inwardly facing surfaces are protrusions comprising barbs.
8. The slotted anchor of claim 1, wherein the inner surfaces of the prongs of the slotted anchor are configured as corresponding inwardly facing U-shaped prongs, and wherein the inner surfaces of the prongs protrude into the connector.
9. The slotted anchor of claim 1, wherein the prongs have a straight lead-in initially before beginning to taper.
10. The slotted anchor of claim 1, wherein the back end is a flattened tube.
11. The slotted anchor of claim 1 , wherein the anchor is formed from a folded member.
12. The slotted anchor of claim 1, wherein the anchor includes a slit along at least a portion of its length.
13. The slotted anchor of claim 14, wherein the slit extends along structure defining the width of the anchor.
14. The slotted anchor of claim 14, wherein the slit extends along structure defining a height of the anchor.
15. The slotted anchor of claim 1, wherein the anchor includes a seating portion spaced from the slot inception.
16. The slotted anchor of claim 33, wherein the slotted anchor includes a seating portion and the seating portion is located at the slot inception.
17. The slotted anchor of claim 19, wherein the slot inception includes at least one barb.
18. The slotted anchor of claim 33, wherein the prongs include terminal ends including inwardly directed protrusions.
19. The slotted anchor of claim 33, wherein the inner surfaces of the prongs of the slotted anchor are configured as corresponding inwardly facing U-shaped prongs, and wherein the inner surfaces of the prongs protrude into the connector.
20. The slotted anchor of claim 1, wherein the prongs include interior planar surfaces leading to internal curved surfaces.
21. The slotted anchor of claim 1 , wherein the prongs include interior curved surfaces along their length.
22. An anchor assembly for applying retractive pressure to tissue, the anchor assembly comprising: a distal anchor, wherein the distal anchor includes a head portion that is connected to a generally perpendicularly oriented tail portion via a connecting mid-section portion; a suture, wherein the suture is attachable and tensioned to the distal anchor; and a slotted proximal anchor for securing a suture as part of a proximal end of an anchor assembly, the slotted anchor device comprising: a flattened-tubular back end; and a pair of spaced apart prongs extending from the back end of the slotted proximal anchor to the front end of the slotted proximal anchor, wherein the prongs join together at a slot inception, and wherein the prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs; wherein the prongs include inwardly facing protrusions that are configured to capture and deform the suture between the protrusions and prevent the suture from disengaging from the slotted proximal anchor once engaged; and wherein inner surfaces of the prongs near the slot inception have a plurality of edges of engagement that deform and compress the suture between the prongs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09791011.1A EP2344048B1 (en) | 2008-07-30 | 2009-07-30 | Slotted anchor device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8494308P | 2008-07-30 | 2008-07-30 | |
US61/084,943 | 2008-07-30 | ||
US12/512,731 US9034001B2 (en) | 2005-05-20 | 2009-07-30 | Slotted anchor device |
US12/512,731 | 2009-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010014825A1 true WO2010014825A1 (en) | 2010-02-04 |
Family
ID=41110963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/052275 WO2010014825A1 (en) | 2008-07-30 | 2009-07-30 | Slotted anchor device |
Country Status (3)
Country | Link |
---|---|
US (1) | US9034001B2 (en) |
EP (1) | EP2344048B1 (en) |
WO (1) | WO2010014825A1 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011079314A2 (en) | 2009-12-23 | 2011-06-30 | Danisco Us Inc. | Compositions and methods of pgl for the increased production of isoprene |
EP2659849A3 (en) * | 2012-05-01 | 2014-01-01 | Covidien LP | Surgical instrument with stamped double-flag jaws |
WO2014147295A1 (en) | 2013-03-20 | 2014-09-25 | Ahlstrom Corporation | Fibrous substrate containing fibers and nanofibrillar polysaccharide |
US8920461B2 (en) | 2012-05-01 | 2014-12-30 | Covidien Lp | Surgical forceps with bifurcated flanged jaw components |
US8968311B2 (en) | 2012-05-01 | 2015-03-03 | Covidien Lp | Surgical instrument with stamped double-flag jaws and actuation mechanism |
US9034009B2 (en) | 2012-05-01 | 2015-05-19 | Covidien Lp | Surgical forceps |
US9504461B2 (en) | 2005-05-20 | 2016-11-29 | Neotract, Inc. | Anchor delivery system |
US9592089B2 (en) | 2012-05-01 | 2017-03-14 | Covidien Lp | Method of assembling a spring-loaded mechanism of a surgical instrument |
US10105132B2 (en) | 2005-05-20 | 2018-10-23 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
US10143461B2 (en) | 2005-05-20 | 2018-12-04 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10265061B2 (en) | 2005-05-20 | 2019-04-23 | Neotract, Inc. | Latching anchor device |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
US10299780B2 (en) | 2005-05-20 | 2019-05-28 | Neotract, Inc. | Apparatus and method for manipulating or retracting tissue and anatomical structure |
CN109833111A (en) * | 2018-11-30 | 2019-06-04 | 微创优通医疗科技(嘉兴)有限公司 | A kind of anchor log and anchoring device |
US10426509B2 (en) | 2005-05-20 | 2019-10-01 | Neotract, Inc. | Median lobe destruction apparatus and method |
US10492792B2 (en) | 2005-05-20 | 2019-12-03 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
WO2020053686A1 (en) * | 2018-09-11 | 2020-03-19 | Medacta International Sa | Bone anchor for attaching a suture thread or ligament |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US11207091B2 (en) | 2016-11-08 | 2021-12-28 | Covidien Lp | Surgical instrument for grasping, treating, and/or dividing tissue |
US11298115B2 (en) | 2020-08-03 | 2022-04-12 | Teleflex Life Sciences Limited | Handle and cartridge system for medical interventions |
EP3797713A4 (en) * | 2019-07-22 | 2022-07-27 | Force Engineering Co., Ltd. | Ligator |
US11672520B2 (en) | 2017-12-23 | 2023-06-13 | Teleflex Life Sciences Limited | Expandable tissue engagement apparatus and method |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060167481A1 (en) * | 2005-01-25 | 2006-07-27 | Esophyx, Inc. | Slitted tissue fixation devices and assemblies for deploying the same |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US8945165B2 (en) * | 2008-09-22 | 2015-02-03 | Smith & Nephew, Inc. | Drive shaft for a surgical tool |
RU2700362C2 (en) * | 2010-09-24 | 2019-09-16 | СпортУэлдинг ГмбХ | Surgical suture retainer |
CN103209647B (en) * | 2010-09-24 | 2017-07-14 | 斯博特威尔丁股份有限公司 | Suture holdfast and the method that suture is fixed for relative sclerous tissues |
US20130274768A1 (en) * | 2012-02-29 | 2013-10-17 | Marker Medical, Llc | Surgical apparatus and method |
US9949753B2 (en) | 2012-09-14 | 2018-04-24 | The Spectranetics Corporation | Tissue slitting methods and systems |
US20140155973A1 (en) * | 2012-12-05 | 2014-06-05 | Spinal Modulation, Inc. | Tissue-captured anchors and methods of use |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
US20140275756A1 (en) * | 2013-03-15 | 2014-09-18 | Neotract, Inc. | Devices, Systems and Methods for Treating Benign Prostatic Hyperplasia and Other Conditions |
EP2967634B1 (en) | 2013-03-15 | 2019-06-05 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US10136913B2 (en) | 2013-03-15 | 2018-11-27 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
US9918737B2 (en) | 2013-03-15 | 2018-03-20 | The Spectranetics Corporation | Medical device for removing an implanted object |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
EP3154446B1 (en) * | 2014-06-15 | 2020-11-18 | Anchora Medical Ltd. | Apparatus for suturing a tissue |
DE102014119531B4 (en) | 2014-12-23 | 2019-06-27 | Infineon Technologies Ag | sensor circuit |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
CN105919695A (en) * | 2016-05-18 | 2016-09-07 | 武汉奥绿新生物科技有限公司 | Anchor for lifting prostate tissue |
JP7141721B2 (en) | 2016-11-13 | 2022-09-26 | アンコラ メディカル リミテッド | Minimally invasive tissue suturing device |
CN110349510A (en) * | 2018-04-08 | 2019-10-18 | 北京环宇蓝博科技有限公司 | A kind of curtain cover for LED display screen |
US11413030B2 (en) * | 2018-11-08 | 2022-08-16 | William MONTROSS | Montross button |
CN111281625B (en) * | 2018-11-30 | 2022-06-17 | 微创优通医疗科技(嘉兴)有限公司 | Anchoring device |
CN111407328A (en) * | 2020-03-27 | 2020-07-14 | 微创优通医疗科技(上海)有限公司 | Anchor and anchoring device |
WO2021222172A2 (en) | 2020-04-29 | 2021-11-04 | DePuy Synthes Products, Inc. | Knotless anchor insertion |
USD1019945S1 (en) | 2021-12-30 | 2024-03-26 | Medos International Sarl | Suture anchor insertion device |
DE102022112285A1 (en) | 2022-05-17 | 2023-11-23 | Karl Storz Se & Co. Kg | Inner shaft, method of manufacture and resectoscope |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5690677A (en) * | 1994-02-17 | 1997-11-25 | Arthrex, Inc. | Method for installing a suture anchor through a cannulated tissue-shifting guide |
WO2004017845A1 (en) * | 2002-08-23 | 2004-03-04 | Kvinno Centre Pty Ltd | Anchoring device and its implementation |
WO2007053516A2 (en) * | 2005-10-28 | 2007-05-10 | Halkey-Roberts Corporation | Tapered anchor for tendon graft |
US20070142846A1 (en) * | 2005-05-20 | 2007-06-21 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US20080065120A1 (en) * | 2005-10-31 | 2008-03-13 | Zannis Anthony D | Surgical instrument, kit and method for creating mattress-type stitches |
Family Cites Families (327)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734299A (en) | 1956-02-14 | Igudolph | ||
US659422A (en) | 1900-06-12 | 1900-10-09 | George W Shidler | Surgical instrument. |
US789467A (en) | 1903-06-12 | 1905-05-09 | Stillman A West | Method of tying knots. |
US780392A (en) | 1903-09-14 | 1905-01-17 | Brown Straw Binder Company | Straw-bundle tie. |
US2360164A (en) * | 1943-12-23 | 1944-10-10 | Edward A Swenson | Clothespin |
US2579192A (en) | 1950-08-15 | 1951-12-18 | George H Sciaroni | Suturing instrument |
US2697624A (en) | 1951-11-03 | 1954-12-21 | John A Thomas | Portable knot tying device |
US2646298A (en) | 1952-07-15 | 1953-07-21 | Joseph C Leary | Method of knot tying |
US2825592A (en) | 1954-01-06 | 1958-03-04 | Semple James Mckenzie | Portable knot tying device for smooth filaments |
US3326586A (en) | 1965-07-09 | 1967-06-20 | Robert M Frost | Snell knot tying tool |
US3470834A (en) | 1968-03-08 | 1969-10-07 | Dennison Mfg Co | Fastener attaching device |
US3521918A (en) | 1968-08-14 | 1970-07-28 | Richard L Hammond | Fishline knotting fixture and cutter |
US3716058A (en) | 1970-07-17 | 1973-02-13 | Atlanta Res Inst | Barbed suture |
US3713680A (en) | 1971-02-09 | 1973-01-30 | S Pagano | Knot typing device for barrel knots |
US3756638A (en) | 1972-02-22 | 1973-09-04 | L Stockberger | Knot tyer |
US3875648A (en) | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US3873140A (en) | 1973-10-15 | 1975-03-25 | Moodus Sports Products | Fish hook holder and knot tying device |
US3931667A (en) | 1974-05-08 | 1976-01-13 | Dennison Manufacturing Company | Interlocking attachment device |
US3976079A (en) | 1974-08-01 | 1976-08-24 | Samuels Peter B | Securing devices for sutures |
US4006747A (en) | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
SU825094A1 (en) | 1976-12-25 | 1981-04-30 | Lovenetskij Petr S | Dilator of prostate |
US4235238A (en) | 1978-05-11 | 1980-11-25 | Olympus Optical Co., Ltd. | Apparatus for suturing coeliac tissues |
US4210148A (en) | 1978-11-03 | 1980-07-01 | Stivala Oscar G | Retention suture system |
DE2853289C2 (en) | 1978-12-09 | 1980-12-18 | B. Braun Melsungen Ag, 3508 Melsungen | Button for surgical use |
JPS5836559Y2 (en) | 1979-05-26 | 1983-08-17 | 三菱鉛筆株式会社 | Head and side-knock type shampoo pencil |
US4409974A (en) | 1981-06-29 | 1983-10-18 | Freedland Jeffrey A | Bone-fixating surgical implant device |
US4513746A (en) | 1981-10-09 | 1985-04-30 | United States Surgical Corp. | Instrument for applying plastic-like surgical fastening devices |
US6656182B1 (en) | 1982-05-20 | 2003-12-02 | John O. Hayhurst | Tissue manipulation |
US4741330A (en) | 1983-05-19 | 1988-05-03 | Hayhurst John O | Method and apparatus for anchoring and manipulating cartilage |
US5417691A (en) | 1982-05-20 | 1995-05-23 | Hayhurst; John O. | Apparatus and method for manipulating and anchoring tissue |
US4823794A (en) | 1982-07-12 | 1989-04-25 | Pierce William S | Surgical pledget |
US5435805A (en) | 1992-08-12 | 1995-07-25 | Vidamed, Inc. | Medical probe device with optical viewing capability |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4493323A (en) | 1982-12-13 | 1985-01-15 | University Of Iowa Research Foundation | Suturing device and method for using same |
US4621640A (en) | 1984-01-09 | 1986-11-11 | Mulhollan James S | Mechanical needle carrier and method for its use |
US4657461A (en) | 1984-10-26 | 1987-04-14 | Smith Gareth J | Anchoring bolt |
US4750492A (en) | 1985-02-27 | 1988-06-14 | Richards Medical Company | Absorbable suture apparatus, method and installer |
US4955913A (en) | 1985-03-28 | 1990-09-11 | Robinson Walter C | Surgical tie |
US4669473A (en) | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
US4705040A (en) | 1985-11-18 | 1987-11-10 | Medi-Tech, Incorporated | Percutaneous fixation of hollow organs |
US4738255A (en) | 1986-04-07 | 1988-04-19 | Biotron Labs, Inc. | Suture anchor system |
US5123914A (en) | 1986-05-19 | 1992-06-23 | Cook Incorporated | Visceral anchor for visceral wall mobilization |
US4762128A (en) | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4714281A (en) | 1987-01-02 | 1987-12-22 | Peck Richard M | Device and method for tying a twisted clinch knot |
US4744364A (en) | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4898156A (en) | 1987-05-18 | 1990-02-06 | Mitek Surgical Products, Inc. | Suture anchor |
US4968315A (en) | 1987-12-15 | 1990-11-06 | Mitek Surgical Products, Inc. | Suture anchor and suture anchor installation tool |
US4899743A (en) | 1987-12-15 | 1990-02-13 | Mitek Surgical Products, Inc. | Suture anchor installation tool |
US4926860A (en) | 1988-02-05 | 1990-05-22 | Flexmedics Corporation | ARthroscopic instrumentation and method |
US5053046A (en) | 1988-08-22 | 1991-10-01 | Woodrow W. Janese | Dural sealing needle and method of use |
US5002550A (en) | 1989-06-06 | 1991-03-26 | Mitek Surgical Products, Inc. | Suture anchor installation tool |
US4946468A (en) | 1989-06-06 | 1990-08-07 | Mitek Surgical Products, Inc. | Suture anchor and suture anchor installation tool |
RU2062121C1 (en) | 1989-10-13 | 1996-06-20 | Давыдов Владимир Александрович | Dilating device |
US5919202A (en) | 1989-12-05 | 1999-07-06 | Yoon; Inbae | Surgical instrument with jaws and movable internal needle and method for use thereof |
US5236445A (en) | 1990-07-02 | 1993-08-17 | American Cyanamid Company | Expandable bone anchor and method of anchoring a suture to a bone |
US5269809A (en) | 1990-07-02 | 1993-12-14 | American Cyanamid Company | Locking mechanism for use with a slotted suture anchor |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5203787A (en) | 1990-11-19 | 1993-04-20 | Biomet, Inc. | Suture retaining arrangement |
WO1992010142A1 (en) | 1990-12-10 | 1992-06-25 | Howmedica Inc. | A device and method for interstitial laser energy delivery |
US5129912B2 (en) | 1991-01-07 | 2000-01-11 | Urohealth Systems Inc | Device and method for applying suture |
US5100421A (en) | 1991-02-05 | 1992-03-31 | Cyprus Endosurgical Tools, Inc. | Christoudias curved needle suture assembly |
DE4106823C1 (en) | 1991-03-04 | 1992-06-25 | Liebscher Kunststofftechnik, 8032 Graefelfing, De | |
US5405352A (en) | 1991-04-09 | 1995-04-11 | Weston; Peter V. | Suture knot, method for its formation and use, and knot forming apparatus |
US5217470A (en) | 1991-04-29 | 1993-06-08 | Weston Peter V | Apparatuses and methods for formation and use of a slipknot as a surgical suture knot |
US5258015A (en) | 1991-05-03 | 1993-11-02 | American Cyanamid Company | Locking filament caps |
US5234454A (en) | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
GB9118670D0 (en) | 1991-08-30 | 1991-10-16 | Mcnicholas Thomas A | Surgical devices and uses thereof |
US5861002A (en) | 1991-10-18 | 1999-01-19 | Desai; Ashvin H. | Endoscopic surgical instrument |
US5411520A (en) | 1991-11-08 | 1995-05-02 | Kensey Nash Corporation | Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use |
ES2128811T3 (en) | 1991-12-03 | 1999-05-16 | Boston Scient Ireland Ltd | SUTURE PIN. |
MX9300607A (en) | 1992-02-06 | 1993-10-01 | American Med Syst | APPARATUS AND METHOD FOR INTERSTITIAL TREATMENT. |
US5217486A (en) | 1992-02-18 | 1993-06-08 | Mitek Surgical Products, Inc. | Suture anchor and installation tool |
US7060077B2 (en) | 1992-09-04 | 2006-06-13 | Boston Scientific Scimed, Inc. | Suturing instruments and methods of use |
US5364408A (en) | 1992-09-04 | 1994-11-15 | Laurus Medical Corporation | Endoscopic suture system |
US5540704A (en) | 1992-09-04 | 1996-07-30 | Laurus Medical Corporation | Endoscopic suture system |
US5578044A (en) | 1992-09-04 | 1996-11-26 | Laurus Medical Corporation | Endoscopic suture system |
US6048351A (en) | 1992-09-04 | 2000-04-11 | Scimed Life Systems, Inc. | Transvaginal suturing system |
US5368599A (en) | 1992-10-08 | 1994-11-29 | United States Surgical Corporation | Surgical fastening apparatus with suture array |
IL103737A (en) | 1992-11-13 | 1997-02-18 | Technion Res & Dev Foundation | Stapler device particularly useful in medical suturing |
US5370646A (en) | 1992-11-16 | 1994-12-06 | Reese; H. William | Bone clamp and installation tool |
US5814073A (en) | 1996-12-13 | 1998-09-29 | Bonutti; Peter M. | Method and apparatus for positioning a suture anchor |
US5380334A (en) | 1993-02-17 | 1995-01-10 | Smith & Nephew Dyonics, Inc. | Soft tissue anchors and systems for implantation |
US5735861A (en) | 1995-09-06 | 1998-04-07 | Wilson-Cook Medical, Inc. | Channel mounted activating mechanism for an endoscopic ligator |
US5334200A (en) | 1993-03-02 | 1994-08-02 | Lanny L. Johnson | Suture knot making device and method for use |
US5330488A (en) | 1993-03-23 | 1994-07-19 | Goldrath Milton H | Verres needle suturing kit |
SE505436C2 (en) | 1993-04-27 | 1997-08-25 | Ams Medinvent Sa | prostatic stent |
US5549630A (en) | 1993-05-14 | 1996-08-27 | Bonutti; Peter M. | Method and apparatus for anchoring a suture |
US5845645A (en) | 1993-05-14 | 1998-12-08 | Bonutti; Peter M. | Method of anchoring a suture |
US5403348A (en) | 1993-05-14 | 1995-04-04 | Bonutti; Peter M. | Suture anchor |
US5716368A (en) | 1993-06-02 | 1998-02-10 | General Surgical Innovations, Inc. | Knotmaker with curved elongate member used in tying a ligature |
US5472446A (en) | 1993-06-02 | 1995-12-05 | De La Torre; Roger A. | Surgical instrument for tying a knot in a length of suture at a remote location |
US5505735A (en) | 1993-06-10 | 1996-04-09 | Mitek Surgical Products, Inc. | Surgical anchor and method for using the same |
US5500000A (en) | 1993-07-01 | 1996-03-19 | United States Surgical Corporation | Soft tissue repair system and method |
US5391182A (en) | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5354271A (en) | 1993-08-05 | 1994-10-11 | Voda Jan K | Vascular sheath |
CA2124651C (en) | 1993-08-20 | 2004-09-28 | David T. Green | Apparatus and method for applying and adjusting an anchoring device |
US5507754A (en) | 1993-08-20 | 1996-04-16 | United States Surgical Corporation | Apparatus and method for applying and adjusting an anchoring device |
US5899911A (en) | 1993-08-25 | 1999-05-04 | Inlet Medical, Inc. | Method of using needle-point suture passer to retract and reinforce ligaments |
US5536273A (en) | 1993-12-09 | 1996-07-16 | Lehrer; Theodor | Apparatus and method of extracorporeally applying and locking laparoscopic suture and loop ligatures |
AU1011595A (en) | 1994-01-13 | 1995-07-20 | Ethicon Inc. | Spiral surgical tack |
CA2141911C (en) | 1994-02-24 | 2002-04-23 | Jude S. Sauer | Surgical crimping device and method of use |
US5545178A (en) | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5470337A (en) | 1994-05-17 | 1995-11-28 | Moss; Gerald | Surgical fastener |
US5630824A (en) | 1994-06-01 | 1997-05-20 | Innovasive Devices, Inc. | Suture attachment device |
US5573540A (en) | 1994-07-18 | 1996-11-12 | Yoon; Inbae | Apparatus and method for suturing an opening in anatomical tissue |
US5501690A (en) | 1994-09-02 | 1996-03-26 | Ethicon Endo-Surgery | Suturing device |
US5545171A (en) | 1994-09-22 | 1996-08-13 | Vidamed, Inc. | Anastomosis catheter |
US5531763A (en) | 1994-10-07 | 1996-07-02 | United States Surgical Corporation | Suture cinching apparatus |
US5480406A (en) | 1994-10-07 | 1996-01-02 | United States Surgical Corporation | Method of employing surgical suturing apparatus to tie knots |
US5554162A (en) | 1994-12-02 | 1996-09-10 | Delange; Gregory S. | Method and device for surgically joining luminal structures |
IL111985A (en) | 1994-12-14 | 1999-04-11 | Medical Influence Technologies | Staple and thread assembly particularly for use in power-driven staplers for medical suturing |
US5665109A (en) | 1994-12-29 | 1997-09-09 | Yoon; Inbae | Methods and apparatus for suturing tissue |
US5550172A (en) | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
RU2112571C1 (en) | 1995-04-11 | 1998-06-10 | Педдер Валерий Викторович | Method for treatment of chronic prostatitis and device for its realization (variants) |
US5593421A (en) | 1995-06-06 | 1997-01-14 | Bauer; William | Suture element delivery device and method |
US6117161A (en) | 1995-06-06 | 2000-09-12 | Li Medical Tecnologies, Inc. | Fastener and fastening method, particularly for fastening sutures to bone |
US6086608A (en) | 1996-02-22 | 2000-07-11 | Smith & Nephew, Inc. | Suture collet |
US5647836A (en) | 1995-09-28 | 1997-07-15 | Blake, Iii; Joseph W. | Method and means for treating female urinary incontinence |
US5800445A (en) | 1995-10-20 | 1998-09-01 | United States Surgical Corporation | Tissue tagging device |
US5690649A (en) | 1995-12-05 | 1997-11-25 | Li Medical Technologies, Inc. | Anchor and anchor installation tool and method |
US5725556A (en) | 1995-12-15 | 1998-03-10 | M & R Medical, Inc. | Suture locking apparatus |
US5626614A (en) | 1995-12-22 | 1997-05-06 | Applied Medical Resources Corporation | T-anchor suturing device and method for using same |
US5791022A (en) * | 1996-01-29 | 1998-08-11 | Bohman; Lars | Cord locking mechanism |
US5697950A (en) | 1996-02-07 | 1997-12-16 | Linvatec Corporation | Pre-loaded suture anchor |
US5707394A (en) | 1996-02-07 | 1998-01-13 | Bristol-Myers Squibb Company | Pre-loaded suture anchor with rigid extension |
US6436107B1 (en) | 1996-02-20 | 2002-08-20 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive surgical procedures |
US5741276A (en) | 1996-03-28 | 1998-04-21 | Innovative Surgical Instruments | Apparatus for facilitating the performance of surgical procedures such as the placement of sutures, ligatures and the like |
EP0893970B1 (en) | 1996-04-19 | 2006-06-21 | Applied Medical Resources Corporation | Grasping clip applier |
US5746753A (en) | 1996-05-13 | 1998-05-05 | Boston Scientific Corporation | Needle grasping apparatus |
FR2750031B1 (en) | 1996-06-19 | 1998-09-18 | Martin Jean Jacques | BONE ANCHORING DEVICE FOR SUTURE WIRE AND INSTRUMENT FOR THE IMPLEMENTATION OF THIS DEVICE |
US5782862A (en) | 1996-07-01 | 1998-07-21 | Bonutti; Peter M. | Suture anchor inserter assembly and method |
US5752963A (en) | 1996-08-19 | 1998-05-19 | Bristol-Myers Squibb Company | Suture anchor driver |
US5718717A (en) | 1996-08-19 | 1998-02-17 | Bonutti; Peter M. | Suture anchor |
US5810848A (en) | 1996-08-21 | 1998-09-22 | Hayhurst; John O. | Suturing system |
US5830221A (en) | 1996-09-20 | 1998-11-03 | United States Surgical Corporation | Coil fastener applier |
US5948001A (en) | 1996-10-03 | 1999-09-07 | United States Surgical Corporation | System for suture anchor placement |
US5814072A (en) | 1996-11-15 | 1998-09-29 | Bonutti; Peter M. | Method and apparatus for use in anchoring a suture |
US5948002A (en) | 1996-11-15 | 1999-09-07 | Bonutti; Peter M. | Apparatus and method for use in positioning a suture anchor |
US5928252A (en) | 1997-01-21 | 1999-07-27 | Regen Biologics, Inc. | Device and method for driving a needle and meniscal repair |
US5964732A (en) | 1997-02-07 | 1999-10-12 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
US5954057A (en) | 1997-02-12 | 1999-09-21 | Li Medical Technologies, Inc. | Soft tissue suspension clip, clip assembly, emplacement tool and method |
US5782864A (en) | 1997-04-03 | 1998-07-21 | Mitek Surgical Products, Inc. | Knotless suture system and method |
US5846254A (en) | 1997-04-08 | 1998-12-08 | Ethicon Endo-Surgery, Inc. | Surgical instrument for forming a knot |
US5964756A (en) | 1997-04-11 | 1999-10-12 | Vidamed, Inc. | Transurethral needle ablation device with replaceable stylet cartridge |
US5919198A (en) | 1997-04-17 | 1999-07-06 | Ethicon Endo-Surgery, Inc. | Disposable cartridge with drivers |
US6120539A (en) | 1997-05-01 | 2000-09-19 | C. R. Bard Inc. | Prosthetic repair fabric |
US5908428A (en) | 1997-05-27 | 1999-06-01 | United States Surgical Corporation | Stitching devices for heart valve replacement surgery |
US6015428A (en) * | 1997-06-03 | 2000-01-18 | Anthony C. Pagedas | Integrally formed suture and suture lock |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
FR2765732B1 (en) | 1997-07-04 | 1999-08-27 | France Telecom | VARIABLE PROPELLER ANTENNA |
US5902321A (en) | 1997-07-25 | 1999-05-11 | Innovasive Devices, Inc. | Device and method for delivering a connector for surgically joining and securing flexible tissue repair members |
US6159234A (en) | 1997-08-01 | 2000-12-12 | Peter M. Bonutti | Method and apparatus for securing a suture |
US6056722A (en) | 1997-09-18 | 2000-05-02 | Iowa-India Investments Company Limited Of Douglas | Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US6551328B2 (en) | 1997-11-03 | 2003-04-22 | Symbiosis Corporation | Surgical instrument for invagination and fundoplication |
US5954747A (en) | 1997-11-20 | 1999-09-21 | Clark; Ron | Meniscus repair anchor system |
US6626919B1 (en) | 1997-12-29 | 2003-09-30 | Lee L. Swanstrom | Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall |
US6068648A (en) | 1998-01-26 | 2000-05-30 | Orthodyne, Inc. | Tissue anchoring system and method |
US6045551A (en) | 1998-02-06 | 2000-04-04 | Bonutti; Peter M. | Bone suture |
US5921986A (en) | 1998-02-06 | 1999-07-13 | Bonutti; Peter M. | Bone suture |
US6280460B1 (en) | 1998-02-13 | 2001-08-28 | Heartport, Inc. | Devices and methods for performing vascular anastomosis |
RU2128012C1 (en) | 1998-03-11 | 1999-03-27 | Оспанов Орал Базарбаевич | Compression anastomosis apparatus |
US5944739A (en) | 1998-03-12 | 1999-08-31 | Surgical Dynamics, Inc. | Suture anchor installation system |
US6010514A (en) | 1998-03-17 | 2000-01-04 | Burney; Bryan T. | Suturing assembly and method of use |
US5931844A (en) | 1998-03-31 | 1999-08-03 | Smith & Nephew, Inc. | Surgical drive tool |
US5971447A (en) | 1998-04-15 | 1999-10-26 | Steck, Iii; William F | Fisherman's knot tying device |
US6143006A (en) | 1998-04-18 | 2000-11-07 | Chan; Kwan-Ho | Apparatus and method for tying and tensioning knots |
US6080167A (en) | 1998-04-28 | 2000-06-27 | Lyell; Mark S. | Anastomotic instrument |
US6216703B1 (en) | 1998-05-08 | 2001-04-17 | Thermatrx, Inc. | Therapeutic prostatic thermotherapy |
AU737877B2 (en) | 1998-05-21 | 2001-09-06 | Christopher J. Walshe | A tissue anchor system |
US6488691B1 (en) | 1998-06-24 | 2002-12-03 | Brendan J. Carroll | Laparascopic incision closure device |
US6261302B1 (en) | 1998-06-26 | 2001-07-17 | Ethicon Endo-Surgery, Inc. | Applier for implantable surgical marker |
US6547725B1 (en) | 1998-08-10 | 2003-04-15 | Coroneo, Inc. | Surgical suture and associated anchoring mechanism for tissue retraction |
US6332889B1 (en) | 1998-08-27 | 2001-12-25 | Onux Medical, Inc. | Surgical suturing instrument and method of use |
US6200329B1 (en) | 1998-08-31 | 2001-03-13 | Smith & Nephew, Inc. | Suture collet |
US6093194A (en) | 1998-09-14 | 2000-07-25 | Endocare, Inc. | Insertion device for stents and methods for use |
US6030393A (en) | 1998-09-15 | 2000-02-29 | Corlew; Earvin L. | Needle and procedure for relieving urinary incontinence |
US6066160A (en) * | 1998-11-23 | 2000-05-23 | Quickie Llc | Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing |
US6110183A (en) | 1998-12-22 | 2000-08-29 | Cook Incorporated | Suture anchor device |
ATE324072T1 (en) | 1998-12-30 | 2006-05-15 | Ethicon Inc | THREAD SECURING DEVICE |
CA2593763C (en) | 1998-12-31 | 2008-11-18 | Kensey Nash Corporation | Tissue fastening devices and delivery means |
US6053908A (en) | 1999-01-07 | 2000-04-25 | Design Standards Corporation | Ratchet assembly for surgical instrument |
US6626913B1 (en) | 1999-03-03 | 2003-09-30 | Smith & Nephew, Inc. | Methods, systems, and instruments for inserting prosthetic implants |
US8137364B2 (en) | 2003-09-11 | 2012-03-20 | Abbott Laboratories | Articulating suturing device and method |
US6228096B1 (en) | 1999-03-31 | 2001-05-08 | Sam R. Marchand | Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material |
WO2000060995A2 (en) | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6258124B1 (en) | 1999-05-10 | 2001-07-10 | C. R. Bard, Inc. | Prosthetic repair fabric |
US6461355B2 (en) | 1999-05-27 | 2002-10-08 | Ams Research Corporation | Insulated electrode and method of assembly |
US6368346B1 (en) | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6506196B1 (en) | 1999-06-22 | 2003-01-14 | Ndo Surgical, Inc. | Device and method for correction of a painful body defect |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6592609B1 (en) | 1999-08-09 | 2003-07-15 | Bonutti 2003 Trust-A | Method and apparatus for securing tissue |
US6527794B1 (en) | 1999-08-10 | 2003-03-04 | Ethicon, Inc. | Self-locking suture anchor |
US6290711B1 (en) | 1999-08-13 | 2001-09-18 | Innovasive Devices, Inc. | Connector device and method for surgically joining and securing flexible tissue repair members |
US6425919B1 (en) | 1999-08-18 | 2002-07-30 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
EP1082941B1 (en) | 1999-09-10 | 2005-03-23 | Zimmer Technology, Inc. | Tissue repair device |
US6358258B1 (en) | 1999-09-14 | 2002-03-19 | Abbott Laboratories | Device and method for performing end-to-side anastomosis |
US6641592B1 (en) | 1999-11-19 | 2003-11-04 | Lsi Solutions, Inc. | System for wound closure |
US7887551B2 (en) | 1999-12-02 | 2011-02-15 | Smith & Nephew, Inc. | Soft tissue attachment and repair |
US6635073B2 (en) | 2000-05-03 | 2003-10-21 | Peter M. Bonutti | Method of securing body tissue |
US6527702B2 (en) | 2000-02-01 | 2003-03-04 | Abbeymoor Medical, Inc. | Urinary flow control device and method |
US6706047B2 (en) | 2000-02-15 | 2004-03-16 | Eva Corporation | Suture support assembly |
JP2004514462A (en) | 2000-03-03 | 2004-05-20 | シー・アール・バード・インク | Tissue adhesion device for endoscope with multiple suction ports |
US6402750B1 (en) | 2000-04-04 | 2002-06-11 | Spinlabs, Llc | Devices and methods for the treatment of spinal disorders |
US6908473B2 (en) | 2000-04-14 | 2005-06-21 | Jeffry B. Skiba | Tissue anchoring devices, biological vessel suspending devices and systems and methods utilizing same |
US6663589B1 (en) | 2000-06-20 | 2003-12-16 | Haim Halevy | Catheter system |
US7141038B2 (en) | 2000-08-07 | 2006-11-28 | Abbeymoor Medical, Inc. | Endourethral device and method |
AU2001286704A1 (en) | 2000-08-24 | 2002-03-04 | Surgical Connections, Inc. | Surgical stabilizer devices and methods |
US6530932B1 (en) | 2000-08-30 | 2003-03-11 | Ethicon Endo-Surgery, Inc. | Anastomosis device having improved tissue presentation |
US6719709B2 (en) | 2000-08-31 | 2004-04-13 | Abbeymoor Medical, Inc. | Diagnostic urethral assembly and method |
US6322112B1 (en) | 2000-09-14 | 2001-11-27 | Franklin R. Duncan | Knot tying methods and apparatus |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6533796B1 (en) | 2000-10-11 | 2003-03-18 | Lsi Solutions, Inc. | Loader for surgical suturing instrument |
US6773438B1 (en) | 2000-10-19 | 2004-08-10 | Ethicon Endo-Surgery | Surgical instrument having a rotary lockout mechanism |
US7485124B2 (en) | 2000-10-19 | 2009-02-03 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a fastener delivery mechanism |
US6551333B2 (en) | 2000-10-19 | 2003-04-22 | Ethicon Endo-Surgery, Inc. | Method for attaching hernia mesh |
US6572626B1 (en) | 2000-10-19 | 2003-06-03 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a fastener delivery mechanism |
US6425900B1 (en) | 2000-10-19 | 2002-07-30 | Ethicon Endo-Surgery | Method for attaching hernia mesh |
US6949064B2 (en) | 2000-10-20 | 2005-09-27 | Bard Brachytherapy, Inc. | Brachytherapy seed deployment system |
WO2002036020A1 (en) | 2000-11-02 | 2002-05-10 | Smith & Nephew, Inc. | Closure device and method for tissue repair |
MXPA03004395A (en) | 2000-11-22 | 2004-04-20 | Bard Peripheral Vascular Inc | High density microwall expanded polytetrafluoroethylene tubular structure. |
US6821282B2 (en) | 2000-11-27 | 2004-11-23 | Scimed Life Systems, Inc. | Full thickness resection device control handle |
US6398795B1 (en) | 2000-11-30 | 2002-06-04 | Scimed Life Systems, Inc. | Stapling and cutting in resectioning for full thickness resection devices |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
WO2002058541A2 (en) | 2001-01-23 | 2002-08-01 | Abbeymoor Medical, Inc. | Endourethral device & method |
US20040030217A1 (en) | 2001-02-02 | 2004-02-12 | Yeung Jeffrey E | Urethral muscle controlled micro-invasive sphincteric closure device |
US6770076B2 (en) | 2001-02-12 | 2004-08-03 | Opus Medical, Inc. | Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device |
US7083638B2 (en) | 2001-02-12 | 2006-08-01 | Arthrocare Corporation | Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device |
US6802846B2 (en) | 2001-02-12 | 2004-10-12 | Ams Research Corporation | Foreign body retrieval device and method |
US6709493B2 (en) | 2001-03-26 | 2004-03-23 | Gore Enterprise Holdings, Inc. | Device for reducing the presence of moisture within an enclosure containing a heat source |
US6926732B2 (en) | 2001-06-01 | 2005-08-09 | Ams Research Corporation | Stent delivery device and method |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
CN101623206B (en) | 2001-06-14 | 2012-09-26 | 苏太克股份有限公司 | Apparatus and method for surgical suturing with thread management |
DE60235757D1 (en) | 2001-06-22 | 2010-05-06 | Abbeymoor Medical Inc | URETHRA PROFILING DEVICE |
US7727248B2 (en) | 2001-06-25 | 2010-06-01 | Ethicon Endo-Surgery, Inc. | Surgical clip |
AU2002322493A1 (en) | 2001-07-10 | 2003-01-29 | Ams Research Corporation | Surgical kit for treating prostate tissue |
US6596013B2 (en) | 2001-09-20 | 2003-07-22 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US6767037B2 (en) | 2001-09-27 | 2004-07-27 | Depuy Mitek, Inc. | Sliding and locking surgical knot |
US6773436B2 (en) | 2001-09-28 | 2004-08-10 | Depuy Mitek, Inc. | Absorbable bone anchor |
EP1434530A2 (en) | 2001-10-12 | 2004-07-07 | AMS Research Corporation | Surgical instrument and method |
EP1441798B1 (en) | 2001-10-18 | 2011-12-07 | Abbeymoor Medical, Inc. | Endourethral device |
US20060167477A1 (en) | 2001-11-20 | 2006-07-27 | Arcia Rovil P | Device and method for performing end-to-side anastomosis |
DE10159470B4 (en) | 2001-12-04 | 2012-12-13 | Ovesco Endoscopy Gmbh | Surgical instrument with anchor device at the head end |
US6572653B1 (en) | 2001-12-07 | 2003-06-03 | Rush E. Simonson | Vertebral implant adapted for posterior insertion |
US6790213B2 (en) | 2002-01-07 | 2004-09-14 | C.R. Bard, Inc. | Implantable prosthesis |
US7402166B2 (en) | 2002-02-15 | 2008-07-22 | A&P Feigl Family Limited Partnership | Devices and methods for positioning sutures |
RU2221501C2 (en) | 2002-02-28 | 2004-01-20 | Оспанов Орал Базарбаевич | Method for laparoscopic performance of compression anastomosis |
EP1482841B1 (en) | 2002-03-14 | 2005-12-07 | Yeung, Jeffery E. | Suture anchor and approximating device |
US6699263B2 (en) | 2002-04-05 | 2004-03-02 | Cook Incorporated | Sliding suture anchor |
US6951565B2 (en) | 2002-04-24 | 2005-10-04 | Linvatec Biomaterials Ltd. | Device for inserting surgical implants |
US8105342B2 (en) * | 2002-05-08 | 2012-01-31 | Apollo Endosurgery, Inc. | Apparatus for ligating/suturing living tissues and system for resecting/suturing living tissues |
US7011688B2 (en) | 2002-05-10 | 2006-03-14 | C.R. Bard, Inc. | Prosthetic repair fabric |
US6736823B2 (en) | 2002-05-10 | 2004-05-18 | C.R. Bard, Inc. | Prosthetic repair fabric |
US6736854B2 (en) | 2002-05-10 | 2004-05-18 | C. R. Bard, Inc. | Prosthetic repair fabric with erosion resistant edge |
ES2376660T3 (en) | 2002-05-17 | 2012-03-15 | Tyco Healthcare Group Lp | ENDOSCOPIC SYSTEM OF ORGAN REMOVAL AND METHOD OF USE OF THE SAME. |
WO2003099346A2 (en) | 2002-05-24 | 2003-12-04 | Angiotech International Ag | Compositions and methods for coating medical implants |
US20040243227A1 (en) | 2002-06-13 | 2004-12-02 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US20050216078A1 (en) | 2002-06-13 | 2005-09-29 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US9226825B2 (en) | 2002-06-13 | 2016-01-05 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8287555B2 (en) | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US7753858B2 (en) | 2002-06-13 | 2010-07-13 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7758637B2 (en) | 2003-02-06 | 2010-07-20 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7753922B2 (en) | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
AU2003245507A1 (en) | 2002-06-13 | 2003-12-31 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US7666193B2 (en) | 2002-06-13 | 2010-02-23 | Guided Delivery Sytems, Inc. | Delivery devices and methods for heart valve repair |
US6715804B2 (en) | 2002-07-05 | 2004-04-06 | Daniel James Beers | Fisherman's knot tier |
WO2004008977A1 (en) | 2002-07-23 | 2004-01-29 | Sherwood Services Ag | Ivs obturator instrument and procedure |
US20040044364A1 (en) | 2002-08-29 | 2004-03-04 | Devries Robert | Tissue fasteners and related deployment systems and methods |
JP2006501033A (en) | 2002-10-01 | 2006-01-12 | アンプル メディカル, インコーポレイテッド | Device, system and method for reshaping a heart valve annulus |
US7329264B2 (en) | 2002-10-07 | 2008-02-12 | Arthrex, Inc. | Instrument handle for storing suture and needles |
US6821283B2 (en) | 2002-10-16 | 2004-11-23 | Civco Medical Instruments, Inc. | Suturing system and method |
US7105004B2 (en) | 2002-10-21 | 2006-09-12 | Start Llc | One-hand locking and releasing handheld medical instrument |
US20090149871A9 (en) | 2002-11-01 | 2009-06-11 | Jonathan Kagan | Devices and methods for treating morbid obesity |
US7090690B2 (en) | 2002-11-19 | 2006-08-15 | Arthrocare Corporation | Devices and methods for repairing soft tissue |
US7340300B2 (en) | 2003-04-25 | 2008-03-04 | Medtronic, Inc. | Neurostimulation delivery during transurethral prostate treatment |
BRPI0410376B1 (en) | 2003-05-16 | 2016-06-14 | Bard Inc C R | endoscopic suture system and single intubation |
JP4338440B2 (en) | 2003-05-22 | 2009-10-07 | Hoya株式会社 | Magnetic guidance means guidance system for endoscope |
US7320701B2 (en) | 2003-06-02 | 2008-01-22 | Linvatec Corporation | Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor |
WO2005018466A2 (en) | 2003-08-26 | 2005-03-03 | Endius, Inc. | Access systems and methods for minimally invasive surgery |
US7303108B2 (en) | 2003-09-29 | 2007-12-04 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument incorporating a multi-stroke firing mechanism with a flexible rack |
US20050273138A1 (en) | 2003-12-19 | 2005-12-08 | Guided Delivery Systems, Inc. | Devices and methods for anchoring tissue |
US20050154401A1 (en) | 2004-01-08 | 2005-07-14 | Scimed Life Systems, Inc. | Suturing device for implantable device |
US7066944B2 (en) | 2004-03-11 | 2006-06-27 | Laufer Michael D | Surgical fastening system |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US20060282081A1 (en) | 2004-04-16 | 2006-12-14 | Fanton Gary S | Apparatus and method for securing tissue to bone with a suture |
US20050251175A1 (en) | 2004-05-07 | 2005-11-10 | Ethicon Endo-Surgery, Inc. | Anchors for use in attachment of bladder tissues to pelvic floor tissues following a prostatectomy |
US20060004410A1 (en) | 2004-05-14 | 2006-01-05 | Nobis Rudolph H | Suture locking and cutting devices and methods |
US7334822B1 (en) | 2004-05-20 | 2008-02-26 | Hines Jr Robert S | Bimini twist knot tying device |
US7112186B2 (en) | 2004-05-26 | 2006-09-26 | Shah Tilak M | Gastro-occlusive device |
US7232448B2 (en) | 2004-06-17 | 2007-06-19 | Ethicon, Inc. - Usa | Minimally invasive stitching device |
US7322974B2 (en) | 2004-08-10 | 2008-01-29 | Medtronic, Inc. | TUNA device with integrated saline reservoir |
US7261710B2 (en) | 2004-10-13 | 2007-08-28 | Medtronic, Inc. | Transurethral needle ablation system |
US9463012B2 (en) | 2004-10-26 | 2016-10-11 | P Tech, Llc | Apparatus for guiding and positioning an implant |
US20060089646A1 (en) | 2004-10-26 | 2006-04-27 | Bonutti Peter M | Devices and methods for stabilizing tissue and implants |
US7833230B2 (en) * | 2005-04-20 | 2010-11-16 | Arthroscopic Innovations Llc | Method and apparatus for providing a passageway |
US7608108B2 (en) | 2005-04-29 | 2009-10-27 | Jmea Corporation | Tissue repair system |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US7896891B2 (en) | 2005-05-20 | 2011-03-01 | Neotract, Inc. | Apparatus and method for manipulating or retracting tissue and anatomical structure |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US7588583B2 (en) | 2005-09-14 | 2009-09-15 | Rhaphis Medical, Inc. | Suturing device, system and method |
US20070112385A1 (en) | 2005-11-15 | 2007-05-17 | Conlon Sean P | Expandable suture anchor |
EP2004243A4 (en) | 2005-12-01 | 2009-12-16 | Ndo Surgical Inc | Devices and methods for endoluminal gastric restriction and tissue manipulation |
EP1996084A1 (en) | 2006-03-22 | 2008-12-03 | Sapphire Medical, Inc. | Suture passer devices and uses thereof |
US7862582B2 (en) | 2006-05-02 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Suture management |
US9084664B2 (en) | 2006-05-19 | 2015-07-21 | Ams Research Corporation | Method and articles for treatment of stress urinary incontinence |
US8870916B2 (en) | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
US9788825B2 (en) | 2006-08-04 | 2017-10-17 | Depuy Mitek, Llc | Suture anchor with relief mechanism |
US9750492B2 (en) | 2006-08-04 | 2017-09-05 | Depuy Mitek, Llc | Suture anchor system with tension relief mechanism |
US20080058710A1 (en) | 2006-08-15 | 2008-03-06 | Wilk Peter J | Surgical kit, closure device, and associated method |
US20080082113A1 (en) | 2006-10-03 | 2008-04-03 | Alure Medical, Inc. | Minimally invasive tissue support |
US8166978B2 (en) | 2006-10-04 | 2012-05-01 | Ethicon Endo-Surgery, Inc. | Methods and systems for manipulating tissue |
US7674275B2 (en) | 2006-10-05 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Suture anchor |
FR2906995B1 (en) | 2006-10-11 | 2009-04-17 | Cie Euro Etude Rech Paroscopie | MULTI-NEEDLE SURGICAL HANDWOOD FOR HOLLOW MEMBER AND CORRESPONDING SYSTEM |
US8702729B2 (en) | 2006-10-13 | 2014-04-22 | Boston Scientific Scimed, Inc. | Placing multiple sutures |
US20080154378A1 (en) | 2006-12-22 | 2008-06-26 | Warsaw Orthopedic, Inc. | Bone implant having engineered surfaces |
US8617185B2 (en) | 2007-02-13 | 2013-12-31 | P Tech, Llc. | Fixation device |
US8128657B2 (en) | 2007-02-27 | 2012-03-06 | Olympus Medical Systems Corp. | Suture instrument |
US7658311B2 (en) | 2007-06-22 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with a geared return mechanism |
US8758366B2 (en) | 2007-07-09 | 2014-06-24 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US20100286106A1 (en) | 2008-03-10 | 2010-11-11 | Yigal Gat | Methods and apparatus for treating the prostate |
US20100023026A1 (en) | 2008-07-25 | 2010-01-28 | Zeiner Mark S | Reloadable laparoscopic fastener deploying device with disposable cartridge for use in a gastric volume reduction procedure |
US9833277B2 (en) | 2009-04-27 | 2017-12-05 | Nxthera, Inc. | Systems and methods for prostate treatment |
-
2009
- 2009-07-30 EP EP09791011.1A patent/EP2344048B1/en active Active
- 2009-07-30 WO PCT/US2009/052275 patent/WO2010014825A1/en active Application Filing
- 2009-07-30 US US12/512,731 patent/US9034001B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5690677A (en) * | 1994-02-17 | 1997-11-25 | Arthrex, Inc. | Method for installing a suture anchor through a cannulated tissue-shifting guide |
WO2004017845A1 (en) * | 2002-08-23 | 2004-03-04 | Kvinno Centre Pty Ltd | Anchoring device and its implementation |
US20070142846A1 (en) * | 2005-05-20 | 2007-06-21 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
WO2007053516A2 (en) * | 2005-10-28 | 2007-05-10 | Halkey-Roberts Corporation | Tapered anchor for tendon graft |
US20080065120A1 (en) * | 2005-10-31 | 2008-03-13 | Zannis Anthony D | Surgical instrument, kit and method for creating mattress-type stitches |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10426509B2 (en) | 2005-05-20 | 2019-10-01 | Neotract, Inc. | Median lobe destruction apparatus and method |
US10143461B2 (en) | 2005-05-20 | 2018-12-04 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US11471148B2 (en) | 2005-05-20 | 2022-10-18 | Teleflex Life Sciences Limited | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10575844B2 (en) | 2005-05-20 | 2020-03-03 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US11090036B2 (en) | 2005-05-20 | 2021-08-17 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10945719B2 (en) | 2005-05-20 | 2021-03-16 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US11504149B2 (en) | 2005-05-20 | 2022-11-22 | Teleflex Life Sciences Limited | Median lobe destruction apparatus and method |
US10265061B2 (en) | 2005-05-20 | 2019-04-23 | Neotract, Inc. | Latching anchor device |
US10299780B2 (en) | 2005-05-20 | 2019-05-28 | Neotract, Inc. | Apparatus and method for manipulating or retracting tissue and anatomical structure |
US10492792B2 (en) | 2005-05-20 | 2019-12-03 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10105132B2 (en) | 2005-05-20 | 2018-10-23 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US9504461B2 (en) | 2005-05-20 | 2016-11-29 | Neotract, Inc. | Anchor delivery system |
US9353375B2 (en) | 2009-12-23 | 2016-05-31 | Danisco Us Inc. | Compositions and methods of PGL for the increased production of isoprene |
WO2011079314A2 (en) | 2009-12-23 | 2011-06-30 | Danisco Us Inc. | Compositions and methods of pgl for the increased production of isoprene |
US8455236B2 (en) | 2009-12-23 | 2013-06-04 | Danisco Us Inc. | Compositions and methods of PGL for the increased production of isoprene |
EP2857518A2 (en) | 2009-12-23 | 2015-04-08 | Danisco US Inc. | Compositions and methods of PGL for the increased production of isoprene |
US8889387B2 (en) | 2009-12-23 | 2014-11-18 | Danisco Us Inc. | Use of recombinant PGL for increased production of isoprene |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
EP2659849A3 (en) * | 2012-05-01 | 2014-01-01 | Covidien LP | Surgical instrument with stamped double-flag jaws |
US9820765B2 (en) | 2012-05-01 | 2017-11-21 | Covidien Lp | Surgical instrument with stamped double-flange jaws |
US11219482B2 (en) | 2012-05-01 | 2022-01-11 | Covidien Lp | Surgical instrument with stamped double-flange jaws and actuation mechanism |
US9345536B2 (en) | 2012-05-01 | 2016-05-24 | Covidien Lp | Surgical forceps with bifurcated flanged jaw components |
US9375263B2 (en) | 2012-05-01 | 2016-06-28 | Covidien Lp | Surgical instrument with stamped double-flange jaws and actuation mechanism |
US10271897B2 (en) | 2012-05-01 | 2019-04-30 | Covidien Lp | Surgical instrument with stamped double-flange jaws and actuation mechanism |
US9668807B2 (en) | 2012-05-01 | 2017-06-06 | Covidien Lp | Simplified spring load mechanism for delivering shaft force of a surgical instrument |
US9592089B2 (en) | 2012-05-01 | 2017-03-14 | Covidien Lp | Method of assembling a spring-loaded mechanism of a surgical instrument |
US10299852B2 (en) | 2012-05-01 | 2019-05-28 | Covidien Lp | Simplified spring-loaded mechanism for delivering shaft force of a surgical instrument |
US11672592B2 (en) | 2012-05-01 | 2023-06-13 | Covidien Lp | Electrosurgical instrument |
US9861378B2 (en) | 2012-05-01 | 2018-01-09 | Covidien Lp | Surgical instrument with stamped double-flange jaws |
US9956030B2 (en) | 2012-05-01 | 2018-05-01 | Covidien Lp | Electrosurgical forceps with stamped double-flange jaws and u-shaped drive actuation mechanism |
US10245100B2 (en) | 2012-05-01 | 2019-04-02 | Covidien Lp | Simplified spring-loaded mechanism for delivering shaft force of a surgical instrument |
US9265571B2 (en) | 2012-05-01 | 2016-02-23 | Covidien Lp | Surgical forceps |
US10588651B2 (en) | 2012-05-01 | 2020-03-17 | Covidien Lp | Surgical instrument with stamped double-flange jaws |
US8920461B2 (en) | 2012-05-01 | 2014-12-30 | Covidien Lp | Surgical forceps with bifurcated flanged jaw components |
US10952789B2 (en) | 2012-05-01 | 2021-03-23 | Covidien Lp | Simplified spring load mechanism for delivering shaft force of a surgical instrument |
US9034009B2 (en) | 2012-05-01 | 2015-05-19 | Covidien Lp | Surgical forceps |
US8968311B2 (en) | 2012-05-01 | 2015-03-03 | Covidien Lp | Surgical instrument with stamped double-flag jaws and actuation mechanism |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
US11331093B2 (en) | 2012-06-29 | 2022-05-17 | Teleflex Life Sciences Limited | Flexible system for delivering an anchor |
US10912637B2 (en) | 2013-03-14 | 2021-02-09 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US11850140B2 (en) | 2013-03-14 | 2023-12-26 | Teleflex Life Sciences Limited | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US11129608B2 (en) | 2013-03-15 | 2021-09-28 | Neotract, Inc. | Anchor delivery system |
US10349932B2 (en) | 2013-03-15 | 2019-07-16 | Neotract, Inc. | Anchor delivery system |
WO2014147295A1 (en) | 2013-03-20 | 2014-09-25 | Ahlstrom Corporation | Fibrous substrate containing fibers and nanofibrillar polysaccharide |
US11207091B2 (en) | 2016-11-08 | 2021-12-28 | Covidien Lp | Surgical instrument for grasping, treating, and/or dividing tissue |
US11672520B2 (en) | 2017-12-23 | 2023-06-13 | Teleflex Life Sciences Limited | Expandable tissue engagement apparatus and method |
WO2020053686A1 (en) * | 2018-09-11 | 2020-03-19 | Medacta International Sa | Bone anchor for attaching a suture thread or ligament |
CN109833111A (en) * | 2018-11-30 | 2019-06-04 | 微创优通医疗科技(嘉兴)有限公司 | A kind of anchor log and anchoring device |
EP3797713A4 (en) * | 2019-07-22 | 2022-07-27 | Force Engineering Co., Ltd. | Ligator |
US11298115B2 (en) | 2020-08-03 | 2022-04-12 | Teleflex Life Sciences Limited | Handle and cartridge system for medical interventions |
US11801041B2 (en) | 2020-08-03 | 2023-10-31 | Teleflex Life Sciences Limited | Handle and cartridge system for medical interventions |
Also Published As
Publication number | Publication date |
---|---|
US20100030263A1 (en) | 2010-02-04 |
EP2344048B1 (en) | 2016-09-07 |
EP2344048A1 (en) | 2011-07-20 |
US9034001B2 (en) | 2015-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9034001B2 (en) | Slotted anchor device | |
US10265061B2 (en) | Latching anchor device | |
US8888799B2 (en) | Coiled anchor device | |
US9149266B2 (en) | Deforming anchor device | |
US10299780B2 (en) | Apparatus and method for manipulating or retracting tissue and anatomical structure | |
US8936609B2 (en) | Apparatus and method for manipulating or retracting tissue and anatomical structure | |
US10143461B2 (en) | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures | |
US20080033456A1 (en) | Integrated handle assembly for anchor delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09791011 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2009791011 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009791011 Country of ref document: EP |